| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Occupational Exposure | 256 | 2024 | 1813 | 22.700 |
Why?
|
| Occupational Diseases | 163 | 2024 | 1490 | 16.180 |
Why?
|
| Asbestos | 55 | 2024 | 251 | 10.910 |
Why?
|
| Lung Neoplasms | 298 | 2024 | 13383 | 9.140 |
Why?
|
| Smoking | 299 | 2024 | 9054 | 8.810 |
Why?
|
| Alcohol Drinking | 166 | 2024 | 4028 | 7.660 |
Why?
|
| Carcinogens | 65 | 2024 | 452 | 7.140 |
Why?
|
| Neoplasms | 254 | 2024 | 22131 | 6.820 |
Why?
|
| Stomach Neoplasms | 70 | 2024 | 1459 | 6.810 |
Why?
|
| Case-Control Studies | 544 | 2024 | 22153 | 6.310 |
Why?
|
| Head and Neck Neoplasms | 96 | 2024 | 2894 | 6.150 |
Why?
|
| Esophageal Neoplasms | 87 | 2024 | 1657 | 6.080 |
Why?
|
| Mesothelioma | 31 | 2020 | 807 | 5.960 |
Why?
|
| Europe | 246 | 2024 | 3415 | 5.300 |
Why?
|
| Lymphoma, Non-Hodgkin | 47 | 2022 | 1372 | 5.030 |
Why?
|
| Risk Factors | 699 | 2024 | 74128 | 4.560 |
Why?
|
| Carcinoma, Squamous Cell | 120 | 2024 | 4021 | 4.350 |
Why?
|
| Diet | 124 | 2024 | 8049 | 3.850 |
Why?
|
| Air Pollutants, Occupational | 33 | 2018 | 407 | 3.680 |
Why?
|
| Tobacco Smoke Pollution | 40 | 2024 | 820 | 3.390 |
Why?
|
| Mouth Neoplasms | 50 | 2021 | 596 | 3.380 |
Why?
|
| Laryngeal Neoplasms | 42 | 2024 | 514 | 3.320 |
Why?
|
| Hydrocarbons | 20 | 2018 | 105 | 3.280 |
Why?
|
| Odds Ratio | 206 | 2024 | 9644 | 3.160 |
Why?
|
| Vehicle Emissions | 21 | 2024 | 655 | 3.150 |
Why?
|
| Tobacco, Smokeless | 20 | 2019 | 133 | 3.150 |
Why?
|
| Environmental Exposure | 73 | 2024 | 4483 | 3.040 |
Why?
|
| September 11 Terrorist Attacks | 10 | 2023 | 105 | 3.000 |
Why?
|
| Italy | 66 | 2024 | 842 | 2.900 |
Why?
|
| Humans | 1372 | 2024 | 760740 | 2.820 |
Why?
|
| Iran | 82 | 2024 | 737 | 2.770 |
Why?
|
| Helicobacter Infections | 15 | 2023 | 391 | 2.770 |
Why?
|
| Male | 944 | 2024 | 360402 | 2.730 |
Why?
|
| Incidence | 213 | 2024 | 21339 | 2.720 |
Why?
|
| Beryllium | 5 | 2024 | 14 | 2.710 |
Why?
|
| Talc | 5 | 2021 | 48 | 2.610 |
Why?
|
| Middle Aged | 743 | 2024 | 220603 | 2.530 |
Why?
|
| Female | 899 | 2024 | 392203 | 2.510 |
Why?
|
| Mortality | 58 | 2024 | 2899 | 2.500 |
Why?
|
| Urinary Bladder Neoplasms | 59 | 2024 | 2223 | 2.470 |
Why?
|
| Vegetables | 48 | 2024 | 1192 | 2.470 |
Why?
|
| Berylliosis | 4 | 2024 | 9 | 2.380 |
Why?
|
| Pleural Neoplasms | 14 | 2019 | 609 | 2.380 |
Why?
|
| Occupations | 43 | 2022 | 516 | 2.370 |
Why?
|
| Aged | 627 | 2024 | 169092 | 2.300 |
Why?
|
| Cohort Studies | 248 | 2024 | 41464 | 2.190 |
Why?
|
| Fruit | 36 | 2024 | 1158 | 2.060 |
Why?
|
| Adult | 612 | 2024 | 220995 | 2.030 |
Why?
|
| Meat | 35 | 2022 | 584 | 2.020 |
Why?
|
| Cause of Death | 64 | 2024 | 3683 | 1.990 |
Why?
|
| Pancreatic Neoplasms | 42 | 2023 | 5369 | 1.990 |
Why?
|
| DNA Adducts | 11 | 2013 | 94 | 1.940 |
Why?
|
| Polymorphism, Genetic | 51 | 2016 | 4242 | 1.920 |
Why?
|
| Mineral Fibers | 12 | 2014 | 26 | 1.910 |
Why?
|
| Liver Neoplasms | 35 | 2024 | 4309 | 1.850 |
Why?
|
| Colorectal Neoplasms | 37 | 2024 | 6927 | 1.830 |
Why?
|
| Risk | 94 | 2023 | 9603 | 1.830 |
Why?
|
| Inhalation Exposure | 18 | 2020 | 432 | 1.780 |
Why?
|
| Adenocarcinoma | 53 | 2024 | 6345 | 1.770 |
Why?
|
| Hodgkin Disease | 23 | 2021 | 1378 | 1.760 |
Why?
|
| Pharyngeal Neoplasms | 28 | 2017 | 113 | 1.740 |
Why?
|
| Genetic Predisposition to Disease | 106 | 2024 | 17878 | 1.730 |
Why?
|
| Lymphoma | 19 | 2020 | 1899 | 1.690 |
Why?
|
| Asia | 38 | 2024 | 616 | 1.660 |
Why?
|
| Mining | 10 | 2020 | 93 | 1.650 |
Why?
|
| Neoplasms, Second Primary | 22 | 2011 | 1051 | 1.630 |
Why?
|
| Glutathione Transferase | 22 | 2013 | 565 | 1.630 |
Why?
|
| Ethanol | 14 | 2022 | 1320 | 1.600 |
Why?
|
| Life Style | 52 | 2024 | 3907 | 1.540 |
Why?
|
| Risk Assessment | 135 | 2023 | 23974 | 1.520 |
Why?
|
| Helicobacter pylori | 12 | 2022 | 381 | 1.510 |
Why?
|
| Oral Hygiene | 7 | 2021 | 132 | 1.490 |
Why?
|
| Hepatitis C | 14 | 2023 | 1580 | 1.490 |
Why?
|
| Polychlorinated Biphenyls | 4 | 2019 | 236 | 1.480 |
Why?
|
| Wood | 12 | 2020 | 92 | 1.470 |
Why?
|
| Logistic Models | 92 | 2024 | 13248 | 1.460 |
Why?
|
| Opium | 17 | 2024 | 27 | 1.440 |
Why?
|
| Social Class | 28 | 2019 | 1993 | 1.430 |
Why?
|
| Body Mass Index | 66 | 2024 | 12942 | 1.430 |
Why?
|
| Kidney Neoplasms | 42 | 2021 | 4252 | 1.410 |
Why?
|
| Papillomavirus Infections | 15 | 2023 | 1612 | 1.400 |
Why?
|
| Tea | 12 | 2022 | 287 | 1.400 |
Why?
|
| Hypopharyngeal Neoplasms | 12 | 2011 | 51 | 1.330 |
Why?
|
| Uruguay | 69 | 2016 | 104 | 1.290 |
Why?
|
| Feeding Behavior | 42 | 2024 | 3183 | 1.270 |
Why?
|
| Carcinoma, Hepatocellular | 23 | 2021 | 2292 | 1.270 |
Why?
|
| Educational Status | 30 | 2023 | 2509 | 1.240 |
Why?
|
| Dust | 15 | 2016 | 487 | 1.230 |
Why?
|
| Oropharyngeal Neoplasms | 14 | 2024 | 491 | 1.230 |
Why?
|
| Carcinoma, Small Cell | 15 | 2022 | 420 | 1.210 |
Why?
|
| Proportional Hazards Models | 73 | 2024 | 12448 | 1.200 |
Why?
|
| Colonic Neoplasms | 8 | 2023 | 2533 | 1.190 |
Why?
|
| Leukemia | 20 | 2023 | 1520 | 1.190 |
Why?
|
| Cardiovascular Diseases | 54 | 2024 | 15498 | 1.180 |
Why?
|
| Nasopharyngeal Neoplasms | 4 | 2022 | 290 | 1.140 |
Why?
|
| Epidemiologic Studies | 18 | 2018 | 673 | 1.130 |
Why?
|
| Aged, 80 and over | 211 | 2024 | 58919 | 1.110 |
Why?
|
| Molecular Epidemiology | 10 | 2012 | 470 | 1.090 |
Why?
|
| Prevalence | 66 | 2024 | 15702 | 1.080 |
Why?
|
| Coffee | 14 | 2022 | 592 | 1.060 |
Why?
|
| Plant Extracts | 5 | 2013 | 497 | 1.060 |
Why?
|
| Polymorphism, Single Nucleotide | 63 | 2024 | 15908 | 1.050 |
Why?
|
| Carcinogens, Environmental | 9 | 2019 | 72 | 1.050 |
Why?
|
| Formaldehyde | 5 | 2019 | 357 | 1.050 |
Why?
|
| Arsenic | 9 | 2022 | 362 | 1.050 |
Why?
|
| Drinking | 4 | 2019 | 198 | 1.040 |
Why?
|
| Herbicides | 8 | 2015 | 105 | 1.030 |
Why?
|
| Ascorbic Acid | 8 | 2024 | 655 | 1.030 |
Why?
|
| Ilex paraguariensis | 8 | 2013 | 8 | 1.020 |
Why?
|
| Small Cell Lung Carcinoma | 7 | 2022 | 423 | 1.010 |
Why?
|
| Prospective Studies | 140 | 2024 | 54364 | 0.980 |
Why?
|
| DNA Methylation | 16 | 2019 | 4392 | 0.970 |
Why?
|
| Animal Husbandry | 3 | 2014 | 64 | 0.970 |
Why?
|
| Confidence Intervals | 48 | 2019 | 2925 | 0.970 |
Why?
|
| Alcoholic Beverages | 13 | 2018 | 264 | 0.970 |
Why?
|
| Dietary Fiber | 8 | 2024 | 758 | 0.960 |
Why?
|
| Rescue Work | 6 | 2023 | 56 | 0.960 |
Why?
|
| Breast Neoplasms | 53 | 2024 | 20988 | 0.950 |
Why?
|
| Copper | 4 | 2024 | 367 | 0.930 |
Why?
|
| Minerals | 5 | 2024 | 283 | 0.930 |
Why?
|
| Cooking | 10 | 2020 | 309 | 0.930 |
Why?
|
| Registries | 50 | 2024 | 8209 | 0.920 |
Why?
|
| Sex Factors | 71 | 2021 | 10549 | 0.910 |
Why?
|
| Epidemiologic Methods | 20 | 2014 | 1335 | 0.910 |
Why?
|
| Carcinoma, Renal Cell | 24 | 2013 | 3164 | 0.900 |
Why?
|
| Diet, Mediterranean | 9 | 2023 | 738 | 0.900 |
Why?
|
| Smoke | 8 | 2023 | 236 | 0.880 |
Why?
|
| Epstein-Barr Virus Infections | 8 | 2023 | 614 | 0.880 |
Why?
|
| Cheese | 3 | 2022 | 38 | 0.880 |
Why?
|
| Livestock | 2 | 2014 | 20 | 0.880 |
Why?
|
| Peritoneal Neoplasms | 6 | 2023 | 710 | 0.870 |
Why?
|
| Coal | 9 | 2014 | 122 | 0.870 |
Why?
|
| Air Pollution, Indoor | 10 | 2020 | 900 | 0.870 |
Why?
|
| Socioeconomic Factors | 48 | 2023 | 7805 | 0.870 |
Why?
|
| Environmental Pollutants | 11 | 2019 | 1277 | 0.860 |
Why?
|
| China | 22 | 2024 | 2374 | 0.860 |
Why?
|
| Poland | 15 | 2019 | 198 | 0.860 |
Why?
|
| Early Detection of Cancer | 14 | 2024 | 3196 | 0.850 |
Why?
|
| Reproductive History | 10 | 2024 | 210 | 0.850 |
Why?
|
| Lymphoma, B-Cell | 11 | 2017 | 938 | 0.850 |
Why?
|
| Silicosis | 4 | 2020 | 47 | 0.830 |
Why?
|
| Europe, Eastern | 22 | 2012 | 72 | 0.830 |
Why?
|
| India | 21 | 2017 | 2286 | 0.820 |
Why?
|
| Smoking Cessation | 20 | 2019 | 2056 | 0.820 |
Why?
|
| Genome-Wide Association Study | 39 | 2022 | 12661 | 0.820 |
Why?
|
| Air Pollution | 13 | 2024 | 2355 | 0.810 |
Why?
|
| Textiles | 4 | 2019 | 45 | 0.810 |
Why?
|
| Disinfectants | 2 | 2019 | 129 | 0.790 |
Why?
|
| Beverages | 10 | 2013 | 821 | 0.790 |
Why?
|
| Hepacivirus | 9 | 2023 | 1330 | 0.790 |
Why?
|
| Developing Countries | 13 | 2022 | 2868 | 0.790 |
Why?
|
| Meat-Packing Industry | 4 | 2007 | 12 | 0.780 |
Why?
|
| Multiple Myeloma | 24 | 2020 | 5144 | 0.770 |
Why?
|
| Health Personnel | 8 | 2024 | 3333 | 0.770 |
Why?
|
| Prostatic Neoplasms | 31 | 2021 | 11107 | 0.770 |
Why?
|
| Phytoestrogens | 1 | 2021 | 59 | 0.770 |
Why?
|
| Hepatitis B | 11 | 2013 | 704 | 0.770 |
Why?
|
| Chemical Industry | 13 | 2008 | 116 | 0.760 |
Why?
|
| Industry | 13 | 2012 | 364 | 0.760 |
Why?
|
| Meta-Analysis as Topic | 22 | 2017 | 1380 | 0.750 |
Why?
|
| New York City | 12 | 2023 | 731 | 0.750 |
Why?
|
| Ovarian Cysts | 1 | 2022 | 108 | 0.750 |
Why?
|
| Time Factors | 71 | 2021 | 39908 | 0.750 |
Why?
|
| Urban Population | 21 | 2020 | 2034 | 0.750 |
Why?
|
| Obesity | 37 | 2024 | 12934 | 0.740 |
Why?
|
| Age Distribution | 38 | 2021 | 2872 | 0.740 |
Why?
|
| Follow-Up Studies | 85 | 2024 | 39062 | 0.740 |
Why?
|
| Volcanic Eruptions | 1 | 2020 | 17 | 0.740 |
Why?
|
| Opiate Alkaloids | 4 | 2022 | 28 | 0.730 |
Why?
|
| Cathartics | 1 | 2021 | 127 | 0.730 |
Why?
|
| Alphapapillomavirus | 3 | 2021 | 218 | 0.720 |
Why?
|
| Vinyl Chloride | 5 | 2013 | 15 | 0.720 |
Why?
|
| Age Factors | 65 | 2024 | 18381 | 0.720 |
Why?
|
| Extraction and Processing Industry | 5 | 2016 | 10 | 0.700 |
Why?
|
| Sweden | 22 | 2024 | 1379 | 0.690 |
Why?
|
| Glycine | 2 | 2021 | 661 | 0.690 |
Why?
|
| Mercury | 8 | 2017 | 290 | 0.680 |
Why?
|
| Nitrosamines | 8 | 2024 | 87 | 0.680 |
Why?
|
| Mouthwashes | 3 | 2024 | 57 | 0.680 |
Why?
|
| Silicon Dioxide | 8 | 2024 | 216 | 0.680 |
Why?
|
| Sodium Chloride, Dietary | 2 | 2022 | 292 | 0.670 |
Why?
|
| DNA Repair | 16 | 2013 | 2043 | 0.660 |
Why?
|
| North America | 22 | 2023 | 1273 | 0.660 |
Why?
|
| Sex Distribution | 29 | 2017 | 2278 | 0.660 |
Why?
|
| Oral Health | 7 | 2024 | 492 | 0.660 |
Why?
|
| Data Collection | 9 | 2014 | 3316 | 0.660 |
Why?
|
| Textile Industry | 9 | 2018 | 74 | 0.650 |
Why?
|
| Chromosomes, Human, Pair 5 | 5 | 2014 | 386 | 0.650 |
Why?
|
| Health Status Disparities | 5 | 2019 | 1846 | 0.650 |
Why?
|
| Paper | 8 | 2006 | 84 | 0.650 |
Why?
|
| Styrenes | 5 | 2009 | 23 | 0.650 |
Why?
|
| Construction Materials | 4 | 2016 | 60 | 0.650 |
Why?
|
| Prognosis | 61 | 2023 | 29601 | 0.640 |
Why?
|
| Gallbladder Diseases | 2 | 2020 | 140 | 0.640 |
Why?
|
| Ubiquitin Thiolesterase | 3 | 2019 | 455 | 0.630 |
Why?
|
| Breast Neoplasms, Male | 3 | 2021 | 212 | 0.620 |
Why?
|
| Permethrin | 1 | 2018 | 15 | 0.620 |
Why?
|
| Residence Characteristics | 8 | 2017 | 2092 | 0.620 |
Why?
|
| Chromosomes, Human, Pair 15 | 5 | 2011 | 361 | 0.620 |
Why?
|
| Tooth Loss | 6 | 2024 | 200 | 0.610 |
Why?
|
| Benzene | 4 | 2024 | 106 | 0.610 |
Why?
|
| Age of Onset | 5 | 2024 | 3303 | 0.610 |
Why?
|
| Diabetes Mellitus | 17 | 2024 | 5838 | 0.610 |
Why?
|
| Russia | 12 | 2021 | 382 | 0.610 |
Why?
|
| Hydrocarbons, Chlorinated | 4 | 2007 | 121 | 0.610 |
Why?
|
| Environment | 8 | 2019 | 1123 | 0.600 |
Why?
|
| Pesticides | 6 | 2012 | 296 | 0.600 |
Why?
|
| Rectal Neoplasms | 5 | 2023 | 1156 | 0.600 |
Why?
|
| Insecticides | 3 | 2018 | 193 | 0.590 |
Why?
|
| Air Pollutants | 11 | 2024 | 2893 | 0.590 |
Why?
|
| Epidemiologic Research Design | 8 | 2018 | 368 | 0.590 |
Why?
|
| Chloroprene | 4 | 2001 | 5 | 0.590 |
Why?
|
| Tobacco Use Disorder | 5 | 2013 | 703 | 0.580 |
Why?
|
| Asbestos, Serpentine | 1 | 2017 | 24 | 0.570 |
Why?
|
| Endometrial Neoplasms | 5 | 2024 | 1365 | 0.570 |
Why?
|
| Antioxidants | 11 | 2024 | 1669 | 0.570 |
Why?
|
| United States | 91 | 2023 | 72292 | 0.570 |
Why?
|
| Genitalia, Female | 1 | 2018 | 147 | 0.570 |
Why?
|
| Latin America | 16 | 2023 | 407 | 0.560 |
Why?
|
| Gases | 1 | 2018 | 204 | 0.560 |
Why?
|
| Research Design | 18 | 2018 | 6174 | 0.560 |
Why?
|
| Carbon Compounds, Inorganic | 1 | 2016 | 12 | 0.560 |
Why?
|
| Silicon Compounds | 1 | 2016 | 16 | 0.560 |
Why?
|
| Publication Bias | 5 | 2018 | 160 | 0.550 |
Why?
|
| Genotype | 55 | 2017 | 12977 | 0.550 |
Why?
|
| Arylamine N-Acetyltransferase | 8 | 2012 | 87 | 0.550 |
Why?
|
| Motor Vehicles | 4 | 2016 | 282 | 0.550 |
Why?
|
| France | 11 | 2017 | 492 | 0.550 |
Why?
|
| Food | 11 | 2023 | 768 | 0.550 |
Why?
|
| International Agencies | 14 | 2020 | 242 | 0.540 |
Why?
|
| Glycemic Index | 4 | 2020 | 396 | 0.540 |
Why?
|
| Australia | 18 | 2022 | 1249 | 0.540 |
Why?
|
| Aldehyde Dehydrogenase | 5 | 2012 | 146 | 0.540 |
Why?
|
| Gallbladder Neoplasms | 3 | 2024 | 189 | 0.540 |
Why?
|
| Asbestos, Amphibole | 1 | 2016 | 7 | 0.540 |
Why?
|
| Menarche | 5 | 2024 | 532 | 0.540 |
Why?
|
| Aging | 11 | 2021 | 8700 | 0.530 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 4 | 2013 | 72 | 0.530 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 17 | 2019 | 1639 | 0.530 |
Why?
|
| Overweight | 14 | 2023 | 2417 | 0.530 |
Why?
|
| Carotenoids | 8 | 2018 | 621 | 0.520 |
Why?
|
| Anticarcinogenic Agents | 7 | 2016 | 249 | 0.520 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 1182 | 0.520 |
Why?
|
| Hepatitis B virus | 7 | 2023 | 527 | 0.520 |
Why?
|
| Ovarian Neoplasms | 13 | 2024 | 4849 | 0.520 |
Why?
|
| Folic Acid | 10 | 2024 | 1323 | 0.520 |
Why?
|
| Survival Rate | 47 | 2024 | 12719 | 0.510 |
Why?
|
| Canada | 21 | 2023 | 2120 | 0.510 |
Why?
|
| Thyroid Neoplasms | 5 | 2022 | 2332 | 0.510 |
Why?
|
| Welding | 3 | 2013 | 89 | 0.510 |
Why?
|
| Population Surveillance | 18 | 2016 | 2597 | 0.510 |
Why?
|
| Rural Population | 16 | 2015 | 2277 | 0.500 |
Why?
|
| Health Behavior | 9 | 2020 | 2643 | 0.500 |
Why?
|
| Acrylamide | 2 | 2017 | 59 | 0.500 |
Why?
|
| Young Adult | 80 | 2024 | 59191 | 0.490 |
Why?
|
| Intestinal Neoplasms | 2 | 2022 | 314 | 0.490 |
Why?
|
| Emigrants and Immigrants | 2 | 2024 | 544 | 0.490 |
Why?
|
| Lymphoma, Follicular | 7 | 2022 | 457 | 0.490 |
Why?
|
| Solvents | 5 | 2010 | 294 | 0.490 |
Why?
|
| Dietary Carbohydrates | 8 | 2015 | 891 | 0.490 |
Why?
|
| Anthropometry | 7 | 2017 | 1338 | 0.490 |
Why?
|
| Meat Products | 10 | 2019 | 96 | 0.480 |
Why?
|
| Romania | 8 | 2016 | 92 | 0.480 |
Why?
|
| Tumor Suppressor Proteins | 9 | 2019 | 2803 | 0.480 |
Why?
|
| Chromosome Aberrations | 5 | 2008 | 1768 | 0.480 |
Why?
|
| Virus Diseases | 2 | 2011 | 718 | 0.480 |
Why?
|
| Particulate Matter | 6 | 2024 | 2602 | 0.480 |
Why?
|
| Hormones | 2 | 2024 | 869 | 0.470 |
Why?
|
| Biliary Tract Neoplasms | 4 | 2023 | 185 | 0.470 |
Why?
|
| Hot Temperature | 6 | 2019 | 1438 | 0.470 |
Why?
|
| Neoplasms, Radiation-Induced | 3 | 2008 | 549 | 0.470 |
Why?
|
| Melanoma | 14 | 2022 | 5696 | 0.470 |
Why?
|
| Sunlight | 9 | 2017 | 337 | 0.470 |
Why?
|
| Databases, Factual | 20 | 2022 | 7963 | 0.470 |
Why?
|
| Polyomavirus Infections | 1 | 2016 | 191 | 0.460 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2018 | 367 | 0.460 |
Why?
|
| Nutritional Status | 10 | 2018 | 1597 | 0.460 |
Why?
|
| RNA, Viral | 3 | 2022 | 2838 | 0.460 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 12 | 2022 | 1405 | 0.450 |
Why?
|
| Antibodies, Viral | 10 | 2024 | 3149 | 0.450 |
Why?
|
| Dose-Response Relationship, Drug | 31 | 2020 | 10754 | 0.450 |
Why?
|
| Purine Nucleosides | 2 | 2011 | 30 | 0.450 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 3 | 2007 | 83 | 0.440 |
Why?
|
| Birth Order | 2 | 2019 | 95 | 0.440 |
Why?
|
| Motor Activity | 8 | 2014 | 2714 | 0.440 |
Why?
|
| Adolescent | 86 | 2024 | 88247 | 0.440 |
Why?
|
| Chronic Disease | 14 | 2024 | 9310 | 0.430 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2019 | 515 | 0.430 |
Why?
|
| Atrazine | 1 | 2013 | 9 | 0.430 |
Why?
|
| Milk | 5 | 2022 | 442 | 0.430 |
Why?
|
| Health Surveys | 10 | 2017 | 4036 | 0.430 |
Why?
|
| Poisson Distribution | 15 | 2017 | 504 | 0.430 |
Why?
|
| Dairy Products | 4 | 2022 | 490 | 0.430 |
Why?
|
| Respiratory Tract Diseases | 9 | 2019 | 750 | 0.420 |
Why?
|
| Regression Analysis | 32 | 2022 | 6339 | 0.420 |
Why?
|
| Lymphoma, T-Cell | 5 | 2013 | 304 | 0.420 |
Why?
|
| Employment | 3 | 2018 | 1113 | 0.420 |
Why?
|
| Carcinoma, Transitional Cell | 6 | 2016 | 782 | 0.420 |
Why?
|
| Waist-Hip Ratio | 9 | 2019 | 518 | 0.410 |
Why?
|
| Cytochrome P-450 CYP1A1 | 5 | 2006 | 90 | 0.410 |
Why?
|
| Hip Fractures | 6 | 2018 | 988 | 0.410 |
Why?
|
| Internationality | 2 | 2015 | 1000 | 0.410 |
Why?
|
| Glycosyltransferases | 1 | 2013 | 115 | 0.400 |
Why?
|
| Deoxyguanosine | 2 | 2011 | 92 | 0.400 |
Why?
|
| World Health Organization | 13 | 2023 | 1321 | 0.400 |
Why?
|
| Hungary | 7 | 2016 | 82 | 0.400 |
Why?
|
| Enzyme Assays | 1 | 2013 | 104 | 0.400 |
Why?
|
| Paranasal Sinus Neoplasms | 5 | 2002 | 242 | 0.400 |
Why?
|
| Uric Acid | 1 | 2018 | 806 | 0.400 |
Why?
|
| Acetaldehyde | 1 | 2011 | 39 | 0.400 |
Why?
|
| Occupational Health | 7 | 2010 | 806 | 0.390 |
Why?
|
| Isothiocyanates | 2 | 2002 | 49 | 0.390 |
Why?
|
| Adenoma | 4 | 2023 | 2159 | 0.390 |
Why?
|
| Asbestosis | 4 | 2019 | 81 | 0.390 |
Why?
|
| Brazil | 11 | 2016 | 1229 | 0.390 |
Why?
|
| Czech Republic | 7 | 2016 | 74 | 0.390 |
Why?
|
| Skin Neoplasms | 15 | 2018 | 5811 | 0.390 |
Why?
|
| Diabetes Complications | 7 | 2019 | 1315 | 0.390 |
Why?
|
| International Classification of Diseases | 1 | 2017 | 912 | 0.380 |
Why?
|
| Review Literature as Topic | 1 | 2014 | 347 | 0.380 |
Why?
|
| Hematocrit | 1 | 2013 | 623 | 0.380 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 2 | 2010 | 89 | 0.380 |
Why?
|
| Thailand | 8 | 2015 | 287 | 0.380 |
Why?
|
| Environmental Pollution | 3 | 2004 | 124 | 0.370 |
Why?
|
| Diabetes Mellitus, Type 2 | 16 | 2023 | 12143 | 0.370 |
Why?
|
| Cholangiocarcinoma | 4 | 2022 | 553 | 0.370 |
Why?
|
| Cross-Sectional Studies | 28 | 2024 | 26065 | 0.370 |
Why?
|
| Ethylene Oxide | 1 | 2010 | 28 | 0.370 |
Why?
|
| Nuts | 3 | 2018 | 264 | 0.370 |
Why?
|
| C-Reactive Protein | 4 | 2014 | 3820 | 0.370 |
Why?
|
| Forecasting | 11 | 2024 | 2924 | 0.360 |
Why?
|
| Cardia | 6 | 2015 | 60 | 0.360 |
Why?
|
| Food Preferences | 5 | 2020 | 398 | 0.360 |
Why?
|
| Physical Fitness | 1 | 2015 | 743 | 0.360 |
Why?
|
| Republic of Korea | 7 | 2024 | 583 | 0.360 |
Why?
|
| Transportation | 1 | 2012 | 217 | 0.360 |
Why?
|
| Bile Ducts, Extrahepatic | 2 | 2022 | 49 | 0.360 |
Why?
|
| Water Pollutants, Chemical | 4 | 2020 | 359 | 0.360 |
Why?
|
| Leukocytes | 6 | 2017 | 2024 | 0.350 |
Why?
|
| Bile Duct Neoplasms | 3 | 2022 | 606 | 0.350 |
Why?
|
| Postmenopause | 7 | 2024 | 2511 | 0.350 |
Why?
|
| Cocarcinogenesis | 9 | 2010 | 49 | 0.350 |
Why?
|
| Menopause | 10 | 2024 | 1645 | 0.350 |
Why?
|
| Lipoproteins | 1 | 2015 | 879 | 0.350 |
Why?
|
| European Union | 10 | 2023 | 157 | 0.350 |
Why?
|
| Titanium | 2 | 2004 | 485 | 0.350 |
Why?
|
| Mood Disorders | 1 | 2017 | 1127 | 0.340 |
Why?
|
| Morbidity | 6 | 2019 | 1750 | 0.340 |
Why?
|
| Genes, p53 | 7 | 2011 | 712 | 0.340 |
Why?
|
| Environmental Monitoring | 11 | 2017 | 1460 | 0.340 |
Why?
|
| Gastrointestinal Neoplasms | 4 | 2020 | 955 | 0.340 |
Why?
|
| Bile Ducts, Intrahepatic | 3 | 2022 | 296 | 0.340 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 4 | 2013 | 56 | 0.340 |
Why?
|
| Lymphocytes | 3 | 2008 | 2604 | 0.340 |
Why?
|
| Mutagens | 5 | 2012 | 179 | 0.340 |
Why?
|
| Genetic Variation | 15 | 2016 | 6561 | 0.340 |
Why?
|
| Digestive System Neoplasms | 4 | 2009 | 83 | 0.330 |
Why?
|
| Inflammation | 10 | 2024 | 10759 | 0.330 |
Why?
|
| Cotinine | 2 | 2010 | 206 | 0.330 |
Why?
|
| Neoplasms, Multiple Primary | 3 | 2018 | 592 | 0.330 |
Why?
|
| Metals, Heavy | 1 | 2011 | 148 | 0.330 |
Why?
|
| Interviews as Topic | 16 | 2014 | 2697 | 0.330 |
Why?
|
| Papillomaviridae | 7 | 2021 | 1117 | 0.330 |
Why?
|
| Agricultural Workers' Diseases | 7 | 2011 | 28 | 0.330 |
Why?
|
| International Cooperation | 9 | 2012 | 1422 | 0.320 |
Why?
|
| DNA Glycosylases | 3 | 2007 | 124 | 0.320 |
Why?
|
| Genetic Association Studies | 5 | 2016 | 2734 | 0.320 |
Why?
|
| Alcohol-Related Disorders | 2 | 2008 | 238 | 0.320 |
Why?
|
| Israel | 14 | 2017 | 716 | 0.320 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2008 | 53 | 0.320 |
Why?
|
| Acrylonitrile | 2 | 2008 | 20 | 0.320 |
Why?
|
| Iron, Dietary | 3 | 2022 | 148 | 0.310 |
Why?
|
| Hazardous Substances | 7 | 2004 | 153 | 0.310 |
Why?
|
| Ultraviolet Rays | 3 | 2013 | 1079 | 0.310 |
Why?
|
| Chromium | 6 | 2024 | 132 | 0.310 |
Why?
|
| Alcohol Dehydrogenase | 5 | 2012 | 111 | 0.310 |
Why?
|
| Premenopause | 6 | 2024 | 1038 | 0.310 |
Why?
|
| Micronutrients | 1 | 2011 | 381 | 0.310 |
Why?
|
| Genetic Loci | 6 | 2018 | 2624 | 0.310 |
Why?
|
| Diet Surveys | 13 | 2019 | 1161 | 0.310 |
Why?
|
| Waist Circumference | 7 | 2023 | 933 | 0.310 |
Why?
|
| Endotoxins | 2 | 2009 | 520 | 0.310 |
Why?
|
| Vietnam | 4 | 2023 | 406 | 0.310 |
Why?
|
| Causality | 11 | 2012 | 1241 | 0.300 |
Why?
|
| Breast Feeding | 4 | 2024 | 1355 | 0.300 |
Why?
|
| Heating | 3 | 2020 | 104 | 0.300 |
Why?
|
| New York | 5 | 2023 | 875 | 0.300 |
Why?
|
| Germany | 10 | 2024 | 872 | 0.300 |
Why?
|
| Hair Dyes | 4 | 2017 | 30 | 0.290 |
Why?
|
| Pathology, Molecular | 2 | 2022 | 329 | 0.290 |
Why?
|
| Japan | 11 | 2024 | 1372 | 0.290 |
Why?
|
| X-Rays | 2 | 2006 | 307 | 0.290 |
Why?
|
| Styrene | 4 | 2004 | 24 | 0.290 |
Why?
|
| Gastroesophageal Reflux | 4 | 2022 | 821 | 0.290 |
Why?
|
| Haplotypes | 14 | 2016 | 2713 | 0.290 |
Why?
|
| SEER Program | 7 | 2022 | 1450 | 0.290 |
Why?
|
| Research Report | 1 | 2011 | 367 | 0.290 |
Why?
|
| DNA Damage | 4 | 2013 | 2445 | 0.290 |
Why?
|
| Obesity, Abdominal | 3 | 2016 | 373 | 0.290 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 7 | 2010 | 276 | 0.290 |
Why?
|
| Diagnostic Errors | 2 | 2014 | 1265 | 0.290 |
Why?
|
| Pneumonia | 4 | 2014 | 2143 | 0.290 |
Why?
|
| Herpesvirus 4, Human | 4 | 2023 | 1077 | 0.280 |
Why?
|
| Metals | 2 | 2011 | 719 | 0.280 |
Why?
|
| Plastics | 4 | 2011 | 117 | 0.280 |
Why?
|
| Factor Analysis, Statistical | 11 | 2013 | 997 | 0.280 |
Why?
|
| Multivariate Analysis | 26 | 2019 | 12043 | 0.280 |
Why?
|
| Family Health | 7 | 2017 | 1253 | 0.280 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2024 | 1434 | 0.280 |
Why?
|
| Food Handling | 2 | 2013 | 154 | 0.280 |
Why?
|
| beta Carotene | 6 | 2014 | 523 | 0.280 |
Why?
|
| Carcinoma, Large Cell | 4 | 2020 | 113 | 0.280 |
Why?
|
| Vaccination | 4 | 2022 | 3370 | 0.280 |
Why?
|
| Brassicaceae | 2 | 2007 | 10 | 0.270 |
Why?
|
| Pesticide Residues | 1 | 2007 | 95 | 0.270 |
Why?
|
| Vitamin E | 4 | 2018 | 872 | 0.270 |
Why?
|
| Pancreatitis | 3 | 2012 | 1097 | 0.270 |
Why?
|
| Eating | 5 | 2024 | 1535 | 0.270 |
Why?
|
| Radiation, Ionizing | 4 | 2020 | 251 | 0.270 |
Why?
|
| Reproducibility of Results | 24 | 2024 | 20077 | 0.270 |
Why?
|
| Hypertension | 13 | 2019 | 8532 | 0.270 |
Why?
|
| Lead | 5 | 2022 | 879 | 0.270 |
Why?
|
| Thinness | 3 | 2022 | 480 | 0.260 |
Why?
|
| Cytogenetics | 1 | 2006 | 198 | 0.260 |
Why?
|
| Gastric Mucosa | 3 | 2019 | 603 | 0.260 |
Why?
|
| Proton Pump Inhibitors | 2 | 2019 | 533 | 0.260 |
Why?
|
| Slovakia | 4 | 2012 | 8 | 0.260 |
Why?
|
| False Positive Reactions | 1 | 2008 | 957 | 0.260 |
Why?
|
| Benzo(a)pyrene | 5 | 2011 | 27 | 0.260 |
Why?
|
| Hormone Replacement Therapy | 4 | 2017 | 751 | 0.260 |
Why?
|
| Telomerase | 3 | 2020 | 744 | 0.250 |
Why?
|
| Death Certificates | 5 | 2021 | 167 | 0.250 |
Why?
|
| Finland | 8 | 2016 | 607 | 0.250 |
Why?
|
| Pandemics | 3 | 2024 | 8652 | 0.250 |
Why?
|
| Barrett Esophagus | 1 | 2009 | 492 | 0.250 |
Why?
|
| Epoxide Hydrolases | 3 | 2013 | 122 | 0.250 |
Why?
|
| Volatile Organic Compounds | 2 | 2024 | 86 | 0.250 |
Why?
|
| Medical Record Linkage | 4 | 2011 | 286 | 0.250 |
Why?
|
| BRCA2 Protein | 3 | 2018 | 797 | 0.240 |
Why?
|
| 2,4,5-Trichlorophenoxyacetic Acid | 2 | 2015 | 15 | 0.240 |
Why?
|
| Eggs | 5 | 2017 | 182 | 0.240 |
Why?
|
| Seroepidemiologic Studies | 5 | 2016 | 398 | 0.240 |
Why?
|
| Family | 4 | 2018 | 3193 | 0.240 |
Why?
|
| 2,4-Dichlorophenoxyacetic Acid | 2 | 2015 | 25 | 0.240 |
Why?
|
| Adiposity | 6 | 2023 | 1879 | 0.240 |
Why?
|
| Public Health | 5 | 2015 | 2671 | 0.240 |
Why?
|
| Mass Screening | 9 | 2022 | 5425 | 0.240 |
Why?
|
| Infant | 23 | 2023 | 36157 | 0.240 |
Why?
|
| Dyslipidemias | 2 | 2017 | 868 | 0.240 |
Why?
|
| Coloring Agents | 2 | 2004 | 562 | 0.240 |
Why?
|
| Parity | 5 | 2024 | 924 | 0.240 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2012 | 2821 | 0.240 |
Why?
|
| Metallurgy | 8 | 2007 | 95 | 0.240 |
Why?
|
| New Zealand | 10 | 2016 | 358 | 0.240 |
Why?
|
| Health Status | 6 | 2017 | 4076 | 0.240 |
Why?
|
| Neoplasm Proteins | 7 | 2014 | 3607 | 0.240 |
Why?
|
| Bayes Theorem | 8 | 2015 | 2327 | 0.230 |
Why?
|
| Major Histocompatibility Complex | 4 | 2015 | 870 | 0.230 |
Why?
|
| Caprylates | 2 | 2016 | 115 | 0.230 |
Why?
|
| Liver Cirrhosis | 5 | 2021 | 1927 | 0.230 |
Why?
|
| Pulmonary Emphysema | 3 | 2015 | 684 | 0.230 |
Why?
|
| Dioxins | 4 | 2008 | 91 | 0.230 |
Why?
|
| Respiratory Tract Neoplasms | 4 | 2014 | 56 | 0.230 |
Why?
|
| Lipids | 1 | 2015 | 3332 | 0.230 |
Why?
|
| Gene Frequency | 11 | 2014 | 3601 | 0.230 |
Why?
|
| Yogurt | 2 | 2022 | 71 | 0.220 |
Why?
|
| Self Report | 7 | 2021 | 3727 | 0.220 |
Why?
|
| Exercise | 11 | 2017 | 5886 | 0.220 |
Why?
|
| Chromosome Disorders | 1 | 2006 | 497 | 0.220 |
Why?
|
| Disease Susceptibility | 7 | 2011 | 1788 | 0.220 |
Why?
|
| Chromosomes, Human | 2 | 2017 | 441 | 0.220 |
Why?
|
| Veterinarians | 1 | 2003 | 13 | 0.220 |
Why?
|
| Superoxide Dismutase | 3 | 2013 | 593 | 0.220 |
Why?
|
| Veterinary Medicine | 1 | 2003 | 21 | 0.220 |
Why?
|
| Sarcoidosis | 1 | 2009 | 520 | 0.220 |
Why?
|
| Drug Users | 2 | 2016 | 134 | 0.220 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 7 | 2024 | 5319 | 0.220 |
Why?
|
| Body Weight | 8 | 2017 | 4615 | 0.220 |
Why?
|
| DNA-Binding Proteins | 8 | 2011 | 9586 | 0.220 |
Why?
|
| Immunologic Surveillance | 1 | 2024 | 92 | 0.220 |
Why?
|
| Nitrates | 2 | 2002 | 263 | 0.220 |
Why?
|
| Sarcoma | 3 | 2022 | 1800 | 0.220 |
Why?
|
| Heart Diseases | 2 | 2015 | 2778 | 0.220 |
Why?
|
| Receptors, Nicotinic | 4 | 2011 | 495 | 0.220 |
Why?
|
| Sewage | 1 | 2023 | 42 | 0.220 |
Why?
|
| Population Groups | 2 | 2021 | 207 | 0.220 |
Why?
|
| Glass | 4 | 2011 | 115 | 0.220 |
Why?
|
| Retrospective Studies | 34 | 2024 | 80583 | 0.210 |
Why?
|
| Multicenter Studies as Topic | 11 | 2011 | 1700 | 0.210 |
Why?
|
| Sphingomyelins | 1 | 2023 | 105 | 0.210 |
Why?
|
| Laundering | 1 | 2002 | 5 | 0.210 |
Why?
|
| Agaricales | 1 | 2023 | 30 | 0.210 |
Why?
|
| Sulfur Dioxide | 2 | 2002 | 178 | 0.210 |
Why?
|
| Hepatitis B, Chronic | 2 | 2021 | 410 | 0.210 |
Why?
|
| Animals | 38 | 2022 | 168202 | 0.210 |
Why?
|
| Eczema | 1 | 2005 | 246 | 0.210 |
Why?
|
| Bronchitis, Chronic | 2 | 2014 | 82 | 0.210 |
Why?
|
| Principal Component Analysis | 10 | 2011 | 943 | 0.210 |
Why?
|
| Agriculture | 4 | 2015 | 187 | 0.210 |
Why?
|
| Acyltransferases | 1 | 2004 | 305 | 0.210 |
Why?
|
| Antibodies, Bacterial | 1 | 2008 | 1464 | 0.210 |
Why?
|
| Trichloroethylene | 2 | 2013 | 13 | 0.200 |
Why?
|
| Trace Elements | 2 | 2015 | 195 | 0.200 |
Why?
|
| Cytochrome P-450 Enzyme System | 4 | 2001 | 412 | 0.200 |
Why?
|
| Alleles | 12 | 2015 | 6861 | 0.200 |
Why?
|
| Biomedical Research | 4 | 2018 | 3426 | 0.200 |
Why?
|
| Alkanesulfonic Acids | 2 | 2016 | 201 | 0.200 |
Why?
|
| Nose Neoplasms | 4 | 1999 | 249 | 0.200 |
Why?
|
| Evidence-Based Medicine | 5 | 2016 | 3680 | 0.200 |
Why?
|
| Survivors | 4 | 2015 | 2373 | 0.200 |
Why?
|
| Bacterial Infections | 1 | 2010 | 1389 | 0.200 |
Why?
|
| Receptors, Calcitriol | 3 | 2009 | 360 | 0.200 |
Why?
|
| Cost of Illness | 6 | 2017 | 1937 | 0.200 |
Why?
|
| Geography | 5 | 2020 | 652 | 0.200 |
Why?
|
| Garlic | 1 | 2022 | 28 | 0.200 |
Why?
|
| Vitamins | 8 | 2015 | 1635 | 0.200 |
Why?
|
| Gastritis, Atrophic | 2 | 2012 | 32 | 0.200 |
Why?
|
| Dietary Supplements | 4 | 2014 | 3412 | 0.200 |
Why?
|
| Fabaceae | 4 | 2017 | 103 | 0.200 |
Why?
|
| Myocardial Ischemia | 3 | 2018 | 2110 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 2 | 3 | 2013 | 313 | 0.200 |
Why?
|
| Maternal Age | 3 | 2018 | 809 | 0.200 |
Why?
|
| Cholelithiasis | 1 | 2023 | 407 | 0.200 |
Why?
|
| Human papillomavirus 16 | 3 | 2014 | 267 | 0.200 |
Why?
|
| Preventive Medicine | 2 | 2019 | 245 | 0.200 |
Why?
|
| Spain | 8 | 2017 | 487 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 12 | 2 | 2015 | 430 | 0.200 |
Why?
|
| Carcinoma | 6 | 2015 | 2328 | 0.200 |
Why?
|
| Butadienes | 2 | 2001 | 107 | 0.200 |
Why?
|
| Receptors, Estrogen | 5 | 2016 | 2208 | 0.190 |
Why?
|
| Gout | 1 | 2009 | 621 | 0.190 |
Why?
|
| Areca | 2 | 2018 | 11 | 0.190 |
Why?
|
| Pentanes | 1 | 2001 | 5 | 0.190 |
Why?
|
| Lead Poisoning | 2 | 2022 | 322 | 0.190 |
Why?
|
| Hemiterpenes | 1 | 2001 | 18 | 0.190 |
Why?
|
| Marital Status | 4 | 2022 | 425 | 0.190 |
Why?
|
| Loss of Heterozygosity | 1 | 2024 | 662 | 0.190 |
Why?
|
| Neoplasms, Experimental | 2 | 2020 | 1226 | 0.190 |
Why?
|
| Trans Fatty Acids | 1 | 2022 | 155 | 0.190 |
Why?
|
| Hydrocarbons, Aromatic | 2 | 2000 | 23 | 0.190 |
Why?
|
| Models, Theoretical | 4 | 2020 | 3567 | 0.190 |
Why?
|
| Neuroblastoma | 2 | 2009 | 1248 | 0.190 |
Why?
|
| Choline | 1 | 2023 | 515 | 0.190 |
Why?
|
| Lung | 8 | 2024 | 9999 | 0.190 |
Why?
|
| Child | 38 | 2024 | 80089 | 0.190 |
Why?
|
| Uterine Cervical Neoplasms | 6 | 2013 | 2020 | 0.190 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2024 | 3245 | 0.190 |
Why?
|
| Infant, Newborn | 19 | 2021 | 26183 | 0.190 |
Why?
|
| Lymphoproliferative Disorders | 3 | 2015 | 531 | 0.190 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 11874 | 0.180 |
Why?
|
| Paint | 1 | 2020 | 34 | 0.180 |
Why?
|
| Sunburn | 3 | 2013 | 156 | 0.180 |
Why?
|
| Chemoprevention | 3 | 2019 | 325 | 0.180 |
Why?
|
| Practice Guidelines as Topic | 4 | 2016 | 7390 | 0.180 |
Why?
|
| Nutrition Assessment | 7 | 2016 | 726 | 0.180 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2021 | 1727 | 0.180 |
Why?
|
| Spouses | 4 | 2016 | 283 | 0.180 |
Why?
|
| Carbon | 4 | 2024 | 665 | 0.180 |
Why?
|
| Risk Reduction Behavior | 4 | 2017 | 1110 | 0.180 |
Why?
|
| Household Articles | 1 | 2020 | 21 | 0.180 |
Why?
|
| Wine | 7 | 2016 | 166 | 0.180 |
Why?
|
| Aluminum | 3 | 2016 | 152 | 0.180 |
Why?
|
| Aspirin | 4 | 2024 | 3127 | 0.180 |
Why?
|
| Life Expectancy | 3 | 2016 | 1242 | 0.180 |
Why?
|
| Hypersensitivity | 3 | 2015 | 1167 | 0.180 |
Why?
|
| Alcoholism | 3 | 2013 | 1972 | 0.180 |
Why?
|
| Delphi Technique | 1 | 2024 | 846 | 0.180 |
Why?
|
| Selection Bias | 4 | 2005 | 359 | 0.180 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2008 | 915 | 0.180 |
Why?
|
| HMGA2 Protein | 1 | 2020 | 102 | 0.180 |
Why?
|
| Women's Health | 7 | 2018 | 2066 | 0.170 |
Why?
|
| Telomere | 2 | 2017 | 942 | 0.170 |
Why?
|
| Tumor Virus Infections | 3 | 2016 | 435 | 0.170 |
Why?
|
| Primary Prevention | 2 | 2019 | 1185 | 0.170 |
Why?
|
| Genetic Testing | 4 | 2020 | 3533 | 0.170 |
Why?
|
| Tuberculosis | 2 | 2015 | 2015 | 0.170 |
Why?
|
| Healthy Worker Effect | 1 | 1999 | 29 | 0.170 |
Why?
|
| Cadmium | 2 | 2011 | 214 | 0.170 |
Why?
|
| Sex Ratio | 1 | 2020 | 107 | 0.170 |
Why?
|
| Fuel Oils | 2 | 2016 | 35 | 0.170 |
Why?
|
| Schistosomiasis | 2 | 1998 | 65 | 0.170 |
Why?
|
| Child, Preschool | 23 | 2021 | 42193 | 0.170 |
Why?
|
| Argentina | 4 | 2010 | 244 | 0.170 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2017 | 1723 | 0.170 |
Why?
|
| Education | 4 | 2014 | 534 | 0.170 |
Why?
|
| Immunity | 2 | 2022 | 994 | 0.170 |
Why?
|
| Colonoscopy | 3 | 2023 | 1397 | 0.170 |
Why?
|
| South America | 5 | 2021 | 179 | 0.170 |
Why?
|
| Stroke | 5 | 2019 | 9715 | 0.170 |
Why?
|
| Sarcoma, Kaposi | 6 | 2000 | 374 | 0.170 |
Why?
|
| Nutrition Surveys | 4 | 2023 | 1725 | 0.170 |
Why?
|
| Genome, Human | 6 | 2018 | 4421 | 0.170 |
Why?
|
| Fluorocarbons | 2 | 2016 | 492 | 0.170 |
Why?
|
| Greece | 5 | 2018 | 340 | 0.170 |
Why?
|
| Blood Proteins | 2 | 2002 | 1172 | 0.170 |
Why?
|
| Norway | 5 | 2016 | 499 | 0.160 |
Why?
|
| Body Height | 5 | 2013 | 1565 | 0.160 |
Why?
|
| Occupational Medicine | 1 | 2019 | 114 | 0.160 |
Why?
|
| Models, Statistical | 14 | 2021 | 5074 | 0.160 |
Why?
|
| Sex Characteristics | 7 | 2019 | 2637 | 0.160 |
Why?
|
| Neoplasm Staging | 13 | 2018 | 11118 | 0.160 |
Why?
|
| Vitamin B 6 | 2 | 2010 | 234 | 0.160 |
Why?
|
| Longevity | 4 | 2014 | 1064 | 0.160 |
Why?
|
| Testicular Neoplasms | 3 | 2015 | 800 | 0.160 |
Why?
|
| Dietary Proteins | 4 | 2017 | 951 | 0.160 |
Why?
|
| Sensitivity and Specificity | 11 | 2021 | 14649 | 0.160 |
Why?
|
| Nails | 2 | 2018 | 296 | 0.160 |
Why?
|
| Citrus | 1 | 2019 | 49 | 0.160 |
Why?
|
| Food Industry | 2 | 2013 | 67 | 0.160 |
Why?
|
| Drinking Behavior | 3 | 2012 | 103 | 0.160 |
Why?
|
| Environmental Health | 2 | 2019 | 288 | 0.160 |
Why?
|
| Electromagnetic Fields | 2 | 2013 | 289 | 0.160 |
Why?
|
| Cocaine | 1 | 2024 | 958 | 0.160 |
Why?
|
| Asthma | 8 | 2016 | 6234 | 0.160 |
Why?
|
| Oxidative Stress | 3 | 2014 | 3115 | 0.150 |
Why?
|
| Mercury Compounds | 1 | 1998 | 7 | 0.150 |
Why?
|
| Blood Buffy Coat | 1 | 2018 | 10 | 0.150 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 2 | 2011 | 304 | 0.150 |
Why?
|
| Marijuana Smoking | 2 | 2013 | 258 | 0.150 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2014 | 1133 | 0.150 |
Why?
|
| Cholecystectomy | 1 | 2020 | 406 | 0.150 |
Why?
|
| Research | 5 | 2017 | 1977 | 0.150 |
Why?
|
| Croatia | 3 | 2016 | 34 | 0.150 |
Why?
|
| Solubility | 1 | 2020 | 1089 | 0.150 |
Why?
|
| Likelihood Functions | 6 | 2014 | 991 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 9 | 2014 | 6074 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2018 | 286 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2015 | 20556 | 0.150 |
Why?
|
| Barbering | 2 | 2015 | 9 | 0.150 |
Why?
|
| Soft Tissue Neoplasms | 2 | 2019 | 1158 | 0.140 |
Why?
|
| HLA Antigens | 4 | 2016 | 1327 | 0.140 |
Why?
|
| Polycyclic Compounds | 1 | 1997 | 29 | 0.140 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2021 | 1241 | 0.140 |
Why?
|
| Pregnancy | 17 | 2024 | 29869 | 0.140 |
Why?
|
| Riboflavin | 2 | 2024 | 107 | 0.140 |
Why?
|
| Hypoglycemic Agents | 5 | 2016 | 3085 | 0.140 |
Why?
|
| Molecular Biology | 1 | 2021 | 575 | 0.140 |
Why?
|
| Opisthorchiasis | 1 | 1997 | 3 | 0.140 |
Why?
|
| Clonorchiasis | 1 | 1997 | 5 | 0.140 |
Why?
|
| Periodontal Diseases | 1 | 2021 | 451 | 0.140 |
Why?
|
| Longitudinal Studies | 8 | 2023 | 14599 | 0.140 |
Why?
|
| Nickel | 3 | 2022 | 128 | 0.140 |
Why?
|
| Flavonoids | 1 | 2020 | 445 | 0.140 |
Why?
|
| Lymphocytosis | 1 | 2018 | 121 | 0.140 |
Why?
|
| Cities | 1 | 2020 | 546 | 0.140 |
Why?
|
| Carcinogenicity Tests | 3 | 2012 | 38 | 0.140 |
Why?
|
| Rubber | 5 | 2016 | 46 | 0.140 |
Why?
|
| Tongue Neoplasms | 2 | 2013 | 183 | 0.140 |
Why?
|
| Urban Health | 4 | 2019 | 532 | 0.140 |
Why?
|
| Genomics | 5 | 2019 | 5822 | 0.140 |
Why?
|
| Creosote | 1 | 2016 | 3 | 0.140 |
Why?
|
| Iron | 3 | 2022 | 1790 | 0.140 |
Why?
|
| Membrane Proteins | 7 | 2016 | 7847 | 0.140 |
Why?
|
| Urologic Neoplasms | 2 | 2014 | 314 | 0.140 |
Why?
|
| Survival Analysis | 12 | 2019 | 10072 | 0.140 |
Why?
|
| Cooperative Behavior | 3 | 2018 | 1505 | 0.140 |
Why?
|
| Family Characteristics | 2 | 2020 | 992 | 0.140 |
Why?
|
| Administration, Inhalation | 1 | 2020 | 1156 | 0.140 |
Why?
|
| Mendelian Randomization Analysis | 3 | 2016 | 1007 | 0.140 |
Why?
|
| Mercury Poisoning | 2 | 1994 | 32 | 0.140 |
Why?
|
| Autoimmune Diseases | 2 | 2022 | 2238 | 0.140 |
Why?
|
| Genes, ras | 3 | 2010 | 654 | 0.140 |
Why?
|
| Malondialdehyde | 2 | 2013 | 112 | 0.140 |
Why?
|
| Hepatitis | 2 | 2016 | 228 | 0.140 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2010 | 631 | 0.140 |
Why?
|
| Social Mobility | 1 | 2016 | 31 | 0.130 |
Why?
|
| Fossil Fuels | 2 | 2005 | 53 | 0.130 |
Why?
|
| Guidelines as Topic | 5 | 2014 | 1386 | 0.130 |
Why?
|
| Platinum | 1 | 1998 | 220 | 0.130 |
Why?
|
| Acidosis, Respiratory | 1 | 2016 | 37 | 0.130 |
Why?
|
| Endocrine System Diseases | 1 | 2018 | 249 | 0.130 |
Why?
|
| Vitamin D | 5 | 2015 | 3301 | 0.130 |
Why?
|
| Nervous System Neoplasms | 2 | 2010 | 91 | 0.130 |
Why?
|
| Consensus | 2 | 2024 | 3117 | 0.130 |
Why?
|
| Disease | 3 | 2011 | 670 | 0.130 |
Why?
|
| HIV Infections | 1 | 2023 | 17342 | 0.130 |
Why?
|
| Denmark | 6 | 2016 | 770 | 0.130 |
Why?
|
| Diphosphonates | 2 | 2018 | 635 | 0.130 |
Why?
|
| Myocardial Infarction | 3 | 2019 | 11458 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 6 | 2024 | 6473 | 0.130 |
Why?
|
| Publishing | 3 | 2015 | 832 | 0.130 |
Why?
|
| Receptors, Progesterone | 3 | 2016 | 1129 | 0.130 |
Why?
|
| Comorbidity | 12 | 2017 | 10507 | 0.130 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2018 | 507 | 0.130 |
Why?
|
| Hematologic Neoplasms | 3 | 2015 | 1896 | 0.130 |
Why?
|
| Allium | 1 | 2015 | 7 | 0.130 |
Why?
|
| Endocrine Disruptors | 2 | 2018 | 264 | 0.130 |
Why?
|
| Reactive Oxygen Species | 2 | 2014 | 2137 | 0.130 |
Why?
|
| Immunoglobulin G | 3 | 2024 | 4533 | 0.130 |
Why?
|
| Shoes | 1 | 1996 | 92 | 0.130 |
Why?
|
| Menstrual Cycle | 2 | 2017 | 539 | 0.130 |
Why?
|
| Body Fat Distribution | 1 | 2017 | 245 | 0.130 |
Why?
|
| Proteins | 4 | 2015 | 6030 | 0.130 |
Why?
|
| Pepsinogen C | 2 | 2012 | 7 | 0.130 |
Why?
|
| Scotland | 1 | 2015 | 143 | 0.130 |
Why?
|
| Autopsy | 2 | 2010 | 1008 | 0.130 |
Why?
|
| Africa, Northern | 2 | 2014 | 86 | 0.130 |
Why?
|
| Inflammation Mediators | 2 | 2014 | 1884 | 0.130 |
Why?
|
| Netherlands | 3 | 2017 | 2222 | 0.130 |
Why?
|
| Pepsinogen A | 2 | 2012 | 14 | 0.130 |
Why?
|
| Cell Cycle | 4 | 2007 | 2929 | 0.130 |
Why?
|
| Recreation | 2 | 2011 | 125 | 0.120 |
Why?
|
| Rad52 DNA Repair and Recombination Protein | 1 | 2015 | 27 | 0.120 |
Why?
|
| Rural Health | 3 | 2019 | 296 | 0.120 |
Why?
|
| Size Perception | 1 | 2015 | 32 | 0.120 |
Why?
|
| Amines | 2 | 2022 | 281 | 0.120 |
Why?
|
| Lipid Peroxidation | 3 | 2011 | 271 | 0.120 |
Why?
|
| Medical Oncology | 1 | 2007 | 2317 | 0.120 |
Why?
|
| Eye Neoplasms | 2 | 2007 | 307 | 0.120 |
Why?
|
| Guideline Adherence | 2 | 2015 | 2218 | 0.120 |
Why?
|
| Vitamin B 12 | 2 | 2024 | 524 | 0.120 |
Why?
|
| Selenium | 3 | 2017 | 417 | 0.120 |
Why?
|
| Antibodies | 1 | 2023 | 2413 | 0.120 |
Why?
|
| Isoenzymes | 4 | 2008 | 1687 | 0.120 |
Why?
|
| Cattle | 3 | 2013 | 3841 | 0.120 |
Why?
|
| Public Policy | 2 | 2019 | 557 | 0.120 |
Why?
|
| Early Termination of Clinical Trials | 1 | 2014 | 67 | 0.120 |
Why?
|
| Water Purification | 2 | 2006 | 60 | 0.120 |
Why?
|
| Glottis | 2 | 2007 | 214 | 0.120 |
Why?
|
| Burkitt Lymphoma | 1 | 2017 | 335 | 0.120 |
Why?
|
| Job Description | 2 | 2004 | 59 | 0.120 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2009 | 2518 | 0.120 |
Why?
|
| Ceramics | 2 | 2006 | 113 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2014 | 8542 | 0.120 |
Why?
|
| Self Disclosure | 2 | 2006 | 249 | 0.110 |
Why?
|
| Lung Diseases | 2 | 2024 | 1909 | 0.110 |
Why?
|
| Health Promotion | 3 | 2013 | 2206 | 0.110 |
Why?
|
| Genes, p16 | 2 | 2012 | 160 | 0.110 |
Why?
|
| Pancreatectomy | 1 | 2018 | 811 | 0.110 |
Why?
|
| Commerce | 2 | 2010 | 608 | 0.110 |
Why?
|
| Dietary Fats | 8 | 2009 | 1995 | 0.110 |
Why?
|
| Sample Size | 2 | 2011 | 838 | 0.110 |
Why?
|
| Sodium Chloride | 3 | 2014 | 586 | 0.110 |
Why?
|
| Accidents, Traffic | 2 | 2018 | 816 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 7 | 2020 | 5780 | 0.110 |
Why?
|
| Data Interpretation, Statistical | 4 | 2012 | 2689 | 0.110 |
Why?
|
| Toxicity Tests | 1 | 2014 | 115 | 0.110 |
Why?
|
| Body Size | 2 | 2014 | 463 | 0.110 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2018 | 1348 | 0.110 |
Why?
|
| Heart Failure | 1 | 2018 | 11670 | 0.110 |
Why?
|
| Nutrition Policy | 2 | 2015 | 466 | 0.110 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2016 | 1135 | 0.110 |
Why?
|
| Water | 1 | 2020 | 1409 | 0.110 |
Why?
|
| Population Dynamics | 2 | 2017 | 306 | 0.110 |
Why?
|
| Radon | 2 | 2006 | 87 | 0.110 |
Why?
|
| Tonsillar Neoplasms | 1 | 2013 | 50 | 0.110 |
Why?
|
| Respiration Disorders | 1 | 2016 | 367 | 0.110 |
Why?
|
| Skin Pigmentation | 3 | 2013 | 277 | 0.110 |
Why?
|
| Immune System Diseases | 1 | 2016 | 254 | 0.110 |
Why?
|
| Lymph Nodes | 2 | 2016 | 3461 | 0.110 |
Why?
|
| Psoriasis | 1 | 2001 | 944 | 0.110 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2015 | 178 | 0.110 |
Why?
|
| Genetic Markers | 3 | 2016 | 2601 | 0.110 |
Why?
|
| Drug Combinations | 1 | 2019 | 2048 | 0.110 |
Why?
|
| Epigenomics | 1 | 2019 | 942 | 0.110 |
Why?
|
| Rats | 3 | 2020 | 23716 | 0.110 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2014 | 302 | 0.110 |
Why?
|
| Fishes | 2 | 2013 | 602 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2014 | 350 | 0.110 |
Why?
|
| Plants, Toxic | 1 | 1993 | 71 | 0.110 |
Why?
|
| Cardiovascular Agents | 1 | 2019 | 840 | 0.110 |
Why?
|
| Half-Life | 1 | 2014 | 650 | 0.110 |
Why?
|
| Sheep | 2 | 2012 | 1436 | 0.110 |
Why?
|
| Secondary Prevention | 1 | 2019 | 1470 | 0.110 |
Why?
|
| Immunoblotting | 3 | 2007 | 1646 | 0.110 |
Why?
|
| Ovulation Inhibition | 1 | 2012 | 4 | 0.100 |
Why?
|
| DNA, Neoplasm | 3 | 2007 | 1743 | 0.100 |
Why?
|
| Lymphoma, T-Cell, Peripheral | 1 | 2014 | 125 | 0.100 |
Why?
|
| Gene Expression Profiling | 4 | 2022 | 9417 | 0.100 |
Why?
|
| Antineoplastic Agents | 4 | 2016 | 13635 | 0.100 |
Why?
|
| Egypt | 7 | 2010 | 96 | 0.100 |
Why?
|
| Vaginal Neoplasms | 1 | 2013 | 104 | 0.100 |
Why?
|
| Mastication | 1 | 2012 | 53 | 0.100 |
Why?
|
| Water Supply | 3 | 2019 | 204 | 0.100 |
Why?
|
| Opioid-Related Disorders | 4 | 2014 | 2164 | 0.100 |
Why?
|
| Information Storage and Retrieval | 2 | 2016 | 819 | 0.100 |
Why?
|
| DNA | 5 | 2011 | 7196 | 0.100 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2019 | 3611 | 0.100 |
Why?
|
| Computer Security | 1 | 2014 | 260 | 0.100 |
Why?
|
| ABO Blood-Group System | 1 | 2015 | 380 | 0.100 |
Why?
|
| American Cancer Society | 2 | 1989 | 69 | 0.100 |
Why?
|
| Antibody Formation | 1 | 2017 | 1390 | 0.100 |
Why?
|
| Genes, BRCA1 | 2 | 2016 | 753 | 0.100 |
Why?
|
| Blood Glucose | 6 | 2024 | 6390 | 0.100 |
Why?
|
| Demography | 6 | 2015 | 1643 | 0.100 |
Why?
|
| Ulcer | 1 | 2013 | 203 | 0.100 |
Why?
|
| Base Sequence | 3 | 2018 | 12420 | 0.100 |
Why?
|
| Digestive System Diseases | 1 | 2013 | 151 | 0.100 |
Why?
|
| Mutation | 9 | 2020 | 30015 | 0.100 |
Why?
|
| Epidemiology | 1 | 1994 | 279 | 0.100 |
Why?
|
| Genital Neoplasms, Female | 2 | 2024 | 532 | 0.100 |
Why?
|
| Gastrins | 1 | 2011 | 75 | 0.100 |
Why?
|
| Horses | 1 | 2012 | 300 | 0.100 |
Why?
|
| Gastric Fundus | 1 | 2011 | 37 | 0.100 |
Why?
|
| Porphobilinogen Synthase | 1 | 2011 | 27 | 0.100 |
Why?
|
| Metformin | 2 | 2016 | 906 | 0.100 |
Why?
|
| Penile Neoplasms | 1 | 2013 | 161 | 0.100 |
Why?
|
| Government Programs | 1 | 2014 | 278 | 0.100 |
Why?
|
| Cisplatin | 1 | 1998 | 1650 | 0.100 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2019 | 940 | 0.100 |
Why?
|
| BRCA1 Protein | 1 | 2018 | 1149 | 0.100 |
Why?
|
| Australasia | 2 | 2021 | 21 | 0.100 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2011 | 105 | 0.090 |
Why?
|
| Computational Biology | 5 | 2015 | 3509 | 0.090 |
Why?
|
| Health Education | 2 | 2018 | 1049 | 0.090 |
Why?
|
| Waldenstrom Macroglobulinemia | 2 | 2018 | 1073 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2012 | 375 | 0.090 |
Why?
|
| Contraceptives, Oral | 2 | 2015 | 553 | 0.090 |
Why?
|
| England | 3 | 1997 | 526 | 0.090 |
Why?
|
| Phenotype | 9 | 2016 | 16572 | 0.090 |
Why?
|
| Receptors, Steroid | 1 | 2011 | 156 | 0.090 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 3204 | 0.090 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 3 | 2009 | 244 | 0.090 |
Why?
|
| Americas | 4 | 2021 | 110 | 0.090 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2012 | 190 | 0.090 |
Why?
|
| Genes, BRCA2 | 2 | 2012 | 590 | 0.090 |
Why?
|
| Membrane Glycoproteins | 2 | 2015 | 3688 | 0.090 |
Why?
|
| Bone Density Conservation Agents | 1 | 2018 | 794 | 0.090 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2012 | 274 | 0.090 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2013 | 504 | 0.090 |
Why?
|
| Ukraine | 2 | 2021 | 149 | 0.090 |
Why?
|
| Neuroendocrine Tumors | 1 | 2017 | 641 | 0.090 |
Why?
|
| DNA Repair Enzymes | 4 | 2018 | 346 | 0.090 |
Why?
|
| Lung Diseases, Obstructive | 3 | 2003 | 308 | 0.090 |
Why?
|
| Analysis of Variance | 5 | 2005 | 6223 | 0.090 |
Why?
|
| STAT Transcription Factors | 1 | 2011 | 188 | 0.090 |
Why?
|
| DNA Helicases | 2 | 2007 | 851 | 0.090 |
Why?
|
| Lactose | 1 | 2010 | 95 | 0.090 |
Why?
|
| Behavior Therapy | 1 | 2016 | 877 | 0.090 |
Why?
|
| Precancerous Conditions | 2 | 2015 | 982 | 0.090 |
Why?
|
| Confidentiality | 1 | 2014 | 608 | 0.090 |
Why?
|
| Chlorophenols | 3 | 1998 | 16 | 0.090 |
Why?
|
| Statistics as Topic | 4 | 2015 | 2358 | 0.090 |
Why?
|
| Lactase | 1 | 2010 | 71 | 0.090 |
Why?
|
| Diabetes, Gestational | 1 | 2020 | 1250 | 0.090 |
Why?
|
| Power Plants | 1 | 1991 | 124 | 0.090 |
Why?
|
| DNA Primers | 1 | 2014 | 2817 | 0.090 |
Why?
|
| Electricity | 1 | 1991 | 175 | 0.090 |
Why?
|
| Apolipoprotein C-I | 1 | 2009 | 13 | 0.090 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2009 | 16 | 0.090 |
Why?
|
| Genetic Heterogeneity | 2 | 2018 | 733 | 0.090 |
Why?
|
| Income | 2 | 2019 | 1870 | 0.090 |
Why?
|
| Janus Kinases | 1 | 2011 | 248 | 0.080 |
Why?
|
| Lymphotoxin-alpha | 1 | 2010 | 93 | 0.080 |
Why?
|
| Tumor Burden | 2 | 2015 | 1892 | 0.080 |
Why?
|
| Gastritis | 1 | 2011 | 199 | 0.080 |
Why?
|
| Ruminants | 2 | 2022 | 5 | 0.080 |
Why?
|
| Preoperative Care | 1 | 2018 | 2242 | 0.080 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2011 | 330 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2010 | 410 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2011 | 453 | 0.080 |
Why?
|
| Anus Neoplasms | 1 | 2013 | 329 | 0.080 |
Why?
|
| Voluntary Health Agencies | 1 | 1989 | 38 | 0.080 |
Why?
|
| Beer | 4 | 2016 | 134 | 0.080 |
Why?
|
| Interpersonal Relations | 2 | 2016 | 1438 | 0.080 |
Why?
|
| Angiotensinogen | 1 | 2010 | 161 | 0.080 |
Why?
|
| Codon | 3 | 2011 | 600 | 0.080 |
Why?
|
| Diet Records | 3 | 2021 | 427 | 0.080 |
Why?
|
| Dental Caries | 1 | 2013 | 427 | 0.080 |
Why?
|
| Engineering | 1 | 2009 | 56 | 0.080 |
Why?
|
| Aflatoxins | 1 | 2008 | 12 | 0.080 |
Why?
|
| Genes, erbB-1 | 1 | 2010 | 162 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2015 | 4340 | 0.080 |
Why?
|
| Chromosome Mapping | 4 | 2024 | 4611 | 0.080 |
Why?
|
| Cadherins | 3 | 2009 | 901 | 0.080 |
Why?
|
| Feasibility Studies | 5 | 2016 | 5239 | 0.080 |
Why?
|
| Cytogenetic Analysis | 2 | 2007 | 270 | 0.080 |
Why?
|
| MicroRNAs | 2 | 2022 | 3802 | 0.080 |
Why?
|
| Brain Neoplasms | 4 | 2019 | 9026 | 0.080 |
Why?
|
| Hospitalization | 5 | 2002 | 10708 | 0.080 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2010 | 208 | 0.080 |
Why?
|
| Awareness | 1 | 2013 | 649 | 0.080 |
Why?
|
| Analgesics, Opioid | 4 | 2022 | 3805 | 0.080 |
Why?
|
| Immunization | 1 | 2013 | 1217 | 0.080 |
Why?
|
| Bulgaria | 2 | 2016 | 17 | 0.080 |
Why?
|
| Knowledge Bases | 1 | 2009 | 97 | 0.080 |
Why?
|
| Carbon Monoxide | 1 | 2012 | 547 | 0.080 |
Why?
|
| Paternal Age | 1 | 2009 | 87 | 0.080 |
Why?
|
| Interleukin-10 | 3 | 2015 | 1171 | 0.080 |
Why?
|
| Tyrosine | 2 | 2005 | 1440 | 0.080 |
Why?
|
| Food Contamination | 2 | 2008 | 191 | 0.080 |
Why?
|
| Moscow | 2 | 1998 | 6 | 0.080 |
Why?
|
| Blood Pressure | 4 | 2024 | 8473 | 0.080 |
Why?
|
| Probability | 2 | 2004 | 2475 | 0.080 |
Why?
|
| Singapore | 3 | 2021 | 292 | 0.080 |
Why?
|
| Vitamin A | 3 | 2000 | 612 | 0.080 |
Why?
|
| Reference Values | 5 | 2013 | 4919 | 0.080 |
Why?
|
| Interleukin-6 | 2 | 2011 | 3205 | 0.080 |
Why?
|
| Fatty Acids, Unsaturated | 4 | 2015 | 540 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2024 | 2270 | 0.080 |
Why?
|
| Alcohol-Induced Disorders | 1 | 2008 | 27 | 0.080 |
Why?
|
| Amino Acid Substitution | 3 | 2007 | 1739 | 0.080 |
Why?
|
| Receptor, erbB-2 | 2 | 2016 | 2553 | 0.080 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 563 | 0.080 |
Why?
|
| Disclosure | 2 | 2011 | 747 | 0.080 |
Why?
|
| Recombination, Genetic | 2 | 2013 | 1519 | 0.080 |
Why?
|
| Signal Transduction | 5 | 2015 | 23415 | 0.080 |
Why?
|
| Human Genome Project | 2 | 2006 | 200 | 0.080 |
Why?
|
| Uterine Neoplasms | 2 | 2014 | 1420 | 0.070 |
Why?
|
| Germ-Line Mutation | 3 | 2018 | 1852 | 0.070 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2009 | 318 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2008 | 1540 | 0.070 |
Why?
|
| Chi-Square Distribution | 6 | 2013 | 3410 | 0.070 |
Why?
|
| Enzymes | 1 | 2009 | 257 | 0.070 |
Why?
|
| Models, Biological | 5 | 2012 | 9461 | 0.070 |
Why?
|
| Swine | 2 | 2012 | 5908 | 0.070 |
Why?
|
| Methionine | 1 | 2010 | 572 | 0.070 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2012 | 487 | 0.070 |
Why?
|
| Liver Transplantation | 1 | 2019 | 2328 | 0.070 |
Why?
|
| Leisure Activities | 1 | 2009 | 308 | 0.070 |
Why?
|
| Wilms Tumor | 1 | 2010 | 379 | 0.070 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2007 | 84 | 0.070 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2007 | 5 | 0.070 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2008 | 265 | 0.070 |
Why?
|
| Metabolic Detoxication, Phase I | 1 | 2007 | 4 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2019 | 10203 | 0.070 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2005 | 318 | 0.070 |
Why?
|
| Terminology as Topic | 2 | 2007 | 1528 | 0.070 |
Why?
|
| Coal Mining | 1 | 2007 | 12 | 0.070 |
Why?
|
| Disabled Persons | 1 | 2017 | 1226 | 0.070 |
Why?
|
| Bronchi | 1 | 2011 | 846 | 0.070 |
Why?
|
| Checklist | 2 | 2011 | 827 | 0.070 |
Why?
|
| Wales | 2 | 1997 | 87 | 0.070 |
Why?
|
| Accidents, Occupational | 2 | 2004 | 249 | 0.070 |
Why?
|
| Linkage Disequilibrium | 4 | 2015 | 1994 | 0.070 |
Why?
|
| Vitamin D Deficiency | 2 | 2014 | 1388 | 0.070 |
Why?
|
| Workplace | 3 | 2007 | 863 | 0.070 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2011 | 1056 | 0.070 |
Why?
|
| Papillomavirus Vaccines | 1 | 2013 | 496 | 0.070 |
Why?
|
| Xenobiotics | 1 | 2007 | 70 | 0.070 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2008 | 217 | 0.070 |
Why?
|
| Knowledge | 1 | 2008 | 177 | 0.070 |
Why?
|
| Genes, Neoplasm | 1 | 2008 | 370 | 0.070 |
Why?
|
| Simian virus 40 | 1 | 2007 | 291 | 0.070 |
Why?
|
| Iron Overload | 1 | 2008 | 239 | 0.070 |
Why?
|
| Fluid Therapy | 1 | 2010 | 577 | 0.070 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2009 | 410 | 0.070 |
Why?
|
| Animals, Domestic | 1 | 2006 | 56 | 0.070 |
Why?
|
| Drug Discovery | 1 | 2014 | 1051 | 0.070 |
Why?
|
| Genes, cdc | 1 | 2006 | 114 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2020 | 9277 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 4 | 2012 | 697 | 0.070 |
Why?
|
| Proto-Oncogenes | 1 | 2007 | 321 | 0.070 |
Why?
|
| Keratins | 1 | 2008 | 498 | 0.070 |
Why?
|
| Fatty Acids | 2 | 2015 | 1808 | 0.070 |
Why?
|
| Slovenia | 2 | 2007 | 22 | 0.070 |
Why?
|
| Apoptosis | 4 | 2010 | 9476 | 0.070 |
Why?
|
| Jejunal Neoplasms | 1 | 2006 | 19 | 0.070 |
Why?
|
| Ileal Neoplasms | 1 | 2006 | 20 | 0.070 |
Why?
|
| Polysaccharides | 1 | 2013 | 1013 | 0.070 |
Why?
|
| Abdomen | 2 | 2011 | 1128 | 0.070 |
Why?
|
| Nicotine | 1 | 2011 | 679 | 0.070 |
Why?
|
| Food Hypersensitivity | 1 | 2014 | 726 | 0.070 |
Why?
|
| Paraffin Embedding | 1 | 2007 | 302 | 0.070 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2008 | 246 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2015 | 4010 | 0.070 |
Why?
|
| Facility Design and Construction | 2 | 2004 | 86 | 0.060 |
Why?
|
| Quebec | 2 | 2006 | 140 | 0.060 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2010 | 512 | 0.060 |
Why?
|
| HIV Seropositivity | 1 | 2011 | 959 | 0.060 |
Why?
|
| Models, Anatomic | 1 | 2009 | 683 | 0.060 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2012 | 831 | 0.060 |
Why?
|
| Chickens | 1 | 2007 | 858 | 0.060 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2010 | 1084 | 0.060 |
Why?
|
| Sleep | 1 | 2021 | 4764 | 0.060 |
Why?
|
| Models, Genetic | 4 | 2011 | 3431 | 0.060 |
Why?
|
| Information Services | 1 | 2007 | 236 | 0.060 |
Why?
|
| Linear Models | 5 | 2019 | 5866 | 0.060 |
Why?
|
| Pilot Projects | 7 | 2022 | 8619 | 0.060 |
Why?
|
| Administration, Oral | 3 | 2020 | 4010 | 0.060 |
Why?
|
| Arabs | 2 | 2017 | 187 | 0.060 |
Why?
|
| Germ Cells | 2 | 2022 | 634 | 0.060 |
Why?
|
| Duodenal Neoplasms | 1 | 2006 | 114 | 0.060 |
Why?
|
| Observer Variation | 2 | 2010 | 2607 | 0.060 |
Why?
|
| Pedigree | 5 | 2018 | 4539 | 0.060 |
Why?
|
| Printing | 1 | 2005 | 46 | 0.060 |
Why?
|
| Health Policy | 2 | 2014 | 2682 | 0.060 |
Why?
|
| Cytochrome P-450 CYP2D6 | 2 | 2015 | 107 | 0.060 |
Why?
|
| DNA Modification Methylases | 3 | 2012 | 210 | 0.060 |
Why?
|
| Wounds and Injuries | 1 | 2017 | 2492 | 0.060 |
Why?
|
| Linoleic Acid | 1 | 2006 | 158 | 0.060 |
Why?
|
| Gastrointestinal Diseases | 1 | 2013 | 1202 | 0.060 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2006 | 161 | 0.060 |
Why?
|
| Weight Gain | 2 | 2012 | 2349 | 0.060 |
Why?
|
| Random Allocation | 3 | 2013 | 2392 | 0.060 |
Why?
|
| Malaysia | 1 | 2024 | 107 | 0.060 |
Why?
|
| Methylmalonic Acid | 1 | 2024 | 49 | 0.060 |
Why?
|
| Leukemia, Lymphoid | 2 | 2016 | 310 | 0.060 |
Why?
|
| Protein Subunits | 1 | 2008 | 942 | 0.060 |
Why?
|
| Nitrogen | 1 | 2006 | 345 | 0.060 |
Why?
|
| Interleukin-2 | 1 | 2011 | 1888 | 0.060 |
Why?
|
| Plants, Edible | 2 | 2003 | 30 | 0.060 |
Why?
|
| Toxicogenetics | 1 | 2004 | 20 | 0.060 |
Why?
|
| Public Opinion | 1 | 2008 | 484 | 0.060 |
Why?
|
| Genetic Techniques | 1 | 2007 | 428 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 2467 | 0.060 |
Why?
|
| Molecular Structure | 1 | 2008 | 1878 | 0.060 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 2007 | 328 | 0.060 |
Why?
|
| alpha-Tocopherol | 2 | 2018 | 126 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2016 | 4512 | 0.060 |
Why?
|
| Peroxidase | 2 | 2004 | 610 | 0.060 |
Why?
|
| Herpesvirus 8, Human | 3 | 2000 | 255 | 0.060 |
Why?
|
| Apolipoproteins E | 1 | 2009 | 1443 | 0.060 |
Why?
|
| Body Weights and Measures | 2 | 2018 | 208 | 0.060 |
Why?
|
| Treatment Outcome | 7 | 2019 | 64572 | 0.060 |
Why?
|
| Toothbrushing | 1 | 2024 | 46 | 0.060 |
Why?
|
| Delivery of Health Care | 3 | 2021 | 5334 | 0.060 |
Why?
|
| Energy Intake | 5 | 2006 | 2133 | 0.060 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2024 | 116 | 0.050 |
Why?
|
| Chenodeoxycholic Acid | 1 | 2023 | 34 | 0.050 |
Why?
|
| National Cancer Institute (U.S.) | 2 | 2015 | 296 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2015 | 3798 | 0.050 |
Why?
|
| Hepatitis C, Chronic | 1 | 2011 | 1018 | 0.050 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2023 | 81 | 0.050 |
Why?
|
| Attitude | 1 | 2008 | 772 | 0.050 |
Why?
|
| Taiwan | 2 | 2015 | 521 | 0.050 |
Why?
|
| Coke | 2 | 2006 | 21 | 0.050 |
Why?
|
| Maternal Exposure | 1 | 2010 | 1067 | 0.050 |
Why?
|
| Steel | 2 | 2006 | 27 | 0.050 |
Why?
|
| Tryptophan | 1 | 2005 | 482 | 0.050 |
Why?
|
| Gasoline | 2 | 2006 | 53 | 0.050 |
Why?
|
| Phytosterols | 2 | 2000 | 55 | 0.050 |
Why?
|
| Jews | 3 | 2000 | 356 | 0.050 |
Why?
|
| Motivation | 1 | 2013 | 2003 | 0.050 |
Why?
|
| Carcinoma in Situ | 1 | 2008 | 791 | 0.050 |
Why?
|
| Habits | 1 | 2003 | 147 | 0.050 |
Why?
|
| CpG Islands | 3 | 2013 | 1192 | 0.050 |
Why?
|
| Estrogens | 1 | 2009 | 1521 | 0.050 |
Why?
|
| Heartburn | 1 | 2022 | 70 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 2 | 2017 | 3593 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2011 | 1890 | 0.050 |
Why?
|
| Biometry | 1 | 2006 | 561 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2011 | 2445 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2005 | 696 | 0.050 |
Why?
|
| Ireland | 2 | 2016 | 170 | 0.050 |
Why?
|
| Chile | 1 | 2023 | 256 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2005 | 2561 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 1932 | 0.050 |
Why?
|
| Coronary Disease | 3 | 2013 | 5911 | 0.050 |
Why?
|
| Nuclear Proteins | 3 | 2018 | 5789 | 0.050 |
Why?
|
| Plant Oils | 1 | 2022 | 198 | 0.050 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2004 | 251 | 0.050 |
Why?
|
| Cytochrome P-450 CYP2E1 | 2 | 2015 | 35 | 0.050 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2007 | 491 | 0.050 |
Why?
|
| Substance-Related Disorders | 1 | 2018 | 4416 | 0.050 |
Why?
|
| B-Lymphocytes | 3 | 2022 | 4745 | 0.050 |
Why?
|
| Predictive Value of Tests | 4 | 2014 | 15250 | 0.050 |
Why?
|
| Georgia | 2 | 2013 | 183 | 0.050 |
Why?
|
| Macrophages, Alveolar | 1 | 2024 | 411 | 0.050 |
Why?
|
| Occupational Health Services | 1 | 2002 | 150 | 0.050 |
Why?
|
| Cystectomy | 2 | 2016 | 634 | 0.050 |
Why?
|
| Arginine | 1 | 2005 | 933 | 0.050 |
Why?
|
| Occult Blood | 1 | 2022 | 197 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 2 | 2011 | 4408 | 0.050 |
Why?
|
| Immunization, Secondary | 1 | 2024 | 368 | 0.050 |
Why?
|
| Pakistan | 1 | 2002 | 292 | 0.050 |
Why?
|
| Dermatologic Agents | 1 | 2005 | 313 | 0.050 |
Why?
|
| Serine | 1 | 2005 | 830 | 0.050 |
Why?
|
| Homocysteine | 1 | 2024 | 637 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2007 | 998 | 0.050 |
Why?
|
| Interleukin-1 | 1 | 2005 | 1248 | 0.050 |
Why?
|
| Acids | 1 | 2021 | 125 | 0.050 |
Why?
|
| Bile Acids and Salts | 1 | 2023 | 393 | 0.050 |
Why?
|
| Epoxy Compounds | 1 | 2001 | 137 | 0.050 |
Why?
|
| Women, Working | 2 | 1999 | 86 | 0.050 |
Why?
|
| Exons | 2 | 2004 | 2381 | 0.050 |
Why?
|
| Lactation | 1 | 2003 | 397 | 0.050 |
Why?
|
| Kerosene | 1 | 2020 | 15 | 0.050 |
Why?
|
| Poverty | 3 | 1997 | 2692 | 0.050 |
Why?
|
| alpha-Fetoproteins | 1 | 2021 | 222 | 0.050 |
Why?
|
| Otorhinolaryngologic Neoplasms | 1 | 2000 | 26 | 0.040 |
Why?
|
| Clinical Trials as Topic | 3 | 2014 | 7995 | 0.040 |
Why?
|
| Biotransformation | 1 | 2000 | 166 | 0.040 |
Why?
|
| Aerosols | 2 | 2006 | 635 | 0.040 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2005 | 604 | 0.040 |
Why?
|
| New South Wales | 1 | 2000 | 69 | 0.040 |
Why?
|
| Cysteine | 1 | 2005 | 891 | 0.040 |
Why?
|
| Genetic Research | 2 | 2011 | 171 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2008 | 1985 | 0.040 |
Why?
|
| Biomass | 1 | 2020 | 127 | 0.040 |
Why?
|
| Gene Silencing | 3 | 2011 | 1503 | 0.040 |
Why?
|
| Estrogen Replacement Therapy | 2 | 2024 | 1208 | 0.040 |
Why?
|
| Sexual Behavior | 1 | 2009 | 2187 | 0.040 |
Why?
|
| Commonwealth of Independent States | 1 | 1999 | 3 | 0.040 |
Why?
|
| Father-Child Relations | 1 | 2000 | 48 | 0.040 |
Why?
|
| DNA Mutational Analysis | 2 | 2007 | 4110 | 0.040 |
Why?
|
| Chromosome Deletion | 1 | 2004 | 1386 | 0.040 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2003 | 384 | 0.040 |
Why?
|
| Asbestos, Crocidolite | 1 | 2019 | 18 | 0.040 |
Why?
|
| alpha-Linolenic Acid | 1 | 2000 | 144 | 0.040 |
Why?
|
| Cognition | 1 | 2017 | 6988 | 0.040 |
Why?
|
| Epigenesis, Genetic | 4 | 2014 | 3794 | 0.040 |
Why?
|
| Hydrochlorothiazide | 1 | 2019 | 94 | 0.040 |
Why?
|
| Hemangiosarcoma | 1 | 2001 | 215 | 0.040 |
Why?
|
| Conflict of Interest | 1 | 2024 | 554 | 0.040 |
Why?
|
| Cholesterol, HDL | 2 | 2017 | 1810 | 0.040 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2014 | 2423 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2003 | 1756 | 0.040 |
Why?
|
| Butanones | 1 | 1998 | 28 | 0.040 |
Why?
|
| Herpesviridae Infections | 1 | 2000 | 269 | 0.040 |
Why?
|
| National Health Programs | 1 | 2002 | 440 | 0.040 |
Why?
|
| Oxidation-Reduction | 2 | 2002 | 2231 | 0.040 |
Why?
|
| Dietary Fats, Unsaturated | 2 | 2010 | 224 | 0.040 |
Why?
|
| Metaplasia | 1 | 2019 | 324 | 0.040 |
Why?
|
| Caffeine | 2 | 2015 | 699 | 0.040 |
Why?
|
| Middle East | 1 | 2019 | 231 | 0.040 |
Why?
|
| Weight Loss | 1 | 2010 | 2682 | 0.040 |
Why?
|
| Scandium | 1 | 2017 | 7 | 0.040 |
Why?
|
| Antigens, Bacterial | 2 | 2015 | 1141 | 0.040 |
Why?
|
| Switzerland | 3 | 2015 | 318 | 0.040 |
Why?
|
| Nitroso Compounds | 1 | 1998 | 71 | 0.040 |
Why?
|
| Triglycerides | 2 | 2017 | 2459 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2007 | 2570 | 0.040 |
Why?
|
| Severity of Illness Index | 4 | 2020 | 15829 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2012 | 3415 | 0.040 |
Why?
|
| Bone Density | 1 | 2011 | 3548 | 0.040 |
Why?
|
| Acetylene | 1 | 1997 | 8 | 0.040 |
Why?
|
| Tars | 1 | 1997 | 20 | 0.040 |
Why?
|
| Pleural Diseases | 1 | 1998 | 137 | 0.040 |
Why?
|
| Alkaloids | 1 | 2019 | 192 | 0.040 |
Why?
|
| Lymphatic Metastasis | 2 | 2013 | 2913 | 0.040 |
Why?
|
| Enalapril | 1 | 2019 | 312 | 0.040 |
Why?
|
| Poultry Products | 1 | 2017 | 10 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2016 | 3514 | 0.040 |
Why?
|
| Tanning | 1 | 1997 | 10 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2002 | 5034 | 0.040 |
Why?
|
| Hazardous Waste | 1 | 1997 | 24 | 0.040 |
Why?
|
| Nutritional Sciences | 2 | 2009 | 144 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2008 | 3447 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2015 | 2872 | 0.030 |
Why?
|
| Hematologic Tests | 1 | 2018 | 239 | 0.030 |
Why?
|
| ROC Curve | 2 | 2015 | 3575 | 0.030 |
Why?
|
| Exodeoxyribonucleases | 1 | 2018 | 191 | 0.030 |
Why?
|
| Heterozygote | 2 | 2018 | 2780 | 0.030 |
Why?
|
| Body Composition | 3 | 2012 | 2426 | 0.030 |
Why?
|
| Albania | 1 | 2016 | 3 | 0.030 |
Why?
|
| Guanine | 1 | 1998 | 278 | 0.030 |
Why?
|
| Glutathione S-Transferase pi | 2 | 2009 | 99 | 0.030 |
Why?
|
| Antigens, Viral | 3 | 2012 | 988 | 0.030 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2020 | 389 | 0.030 |
Why?
|
| Quantitative Trait Loci | 2 | 2015 | 2112 | 0.030 |
Why?
|
| Nitrogen Compounds | 1 | 1996 | 6 | 0.030 |
Why?
|
| Temperature | 1 | 2003 | 2224 | 0.030 |
Why?
|
| Inheritance Patterns | 1 | 2018 | 341 | 0.030 |
Why?
|
| Fertilizers | 1 | 1996 | 24 | 0.030 |
Why?
|
| Mice | 2 | 2020 | 81368 | 0.030 |
Why?
|
| Portugal | 1 | 2016 | 91 | 0.030 |
Why?
|
| Oral Submucous Fibrosis | 1 | 2015 | 2 | 0.030 |
Why?
|
| Male Urogenital Diseases | 1 | 1996 | 48 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2018 | 520 | 0.030 |
Why?
|
| Nitrate Reductase | 1 | 2015 | 11 | 0.030 |
Why?
|
| Quality Control | 1 | 1999 | 831 | 0.030 |
Why?
|
| Female Urogenital Diseases | 1 | 1996 | 57 | 0.030 |
Why?
|
| Austria | 1 | 2016 | 206 | 0.030 |
Why?
|
| Urinalysis | 1 | 2018 | 368 | 0.030 |
Why?
|
| Debrisoquin | 1 | 1995 | 6 | 0.030 |
Why?
|
| Hepatitis B Surface Antigens | 2 | 2012 | 294 | 0.030 |
Why?
|
| Calcium | 2 | 2024 | 5717 | 0.030 |
Why?
|
| Electronics | 1 | 1997 | 317 | 0.030 |
Why?
|
| Seafood | 2 | 2013 | 393 | 0.030 |
Why?
|
| Coal Tar | 2 | 2006 | 17 | 0.030 |
Why?
|
| Immunotoxins | 1 | 2016 | 175 | 0.030 |
Why?
|
| Chaperonin 60 | 1 | 2015 | 97 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 2 | 2014 | 1483 | 0.030 |
Why?
|
| Marriage | 1 | 2017 | 349 | 0.030 |
Why?
|
| Leukoplakia, Oral | 1 | 2015 | 77 | 0.030 |
Why?
|
| Prostate-Specific Antigen | 2 | 2016 | 2465 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2016 | 2896 | 0.030 |
Why?
|
| Immune System | 2 | 2016 | 791 | 0.030 |
Why?
|
| Diabetes Insipidus | 1 | 2015 | 144 | 0.030 |
Why?
|
| Cholesterol, Dietary | 1 | 2015 | 224 | 0.030 |
Why?
|
| Oral Ulcer | 1 | 2015 | 96 | 0.030 |
Why?
|
| Physical Chromosome Mapping | 1 | 2015 | 183 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2020 | 1185 | 0.030 |
Why?
|
| Accidental Falls | 1 | 2003 | 1067 | 0.030 |
Why?
|
| Research Support as Topic | 1 | 1999 | 697 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 18220 | 0.030 |
Why?
|
| Pulmonary Fibrosis | 1 | 1998 | 505 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2018 | 1525 | 0.030 |
Why?
|
| Osteopontin | 1 | 2016 | 301 | 0.030 |
Why?
|
| Paraquat | 1 | 2014 | 32 | 0.030 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2019 | 687 | 0.030 |
Why?
|
| Hair | 1 | 2018 | 498 | 0.030 |
Why?
|
| Serpins | 1 | 2016 | 247 | 0.030 |
Why?
|
| Interdisciplinary Communication | 2 | 2011 | 928 | 0.030 |
Why?
|
| Drug Repositioning | 1 | 2016 | 233 | 0.030 |
Why?
|
| Reproduction | 1 | 2018 | 646 | 0.030 |
Why?
|
| Clothing | 1 | 1994 | 96 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2020 | 1566 | 0.030 |
Why?
|
| Intra-Abdominal Fat | 1 | 2019 | 612 | 0.030 |
Why?
|
| Pancreas | 1 | 2021 | 1691 | 0.030 |
Why?
|
| Mouth | 1 | 2016 | 381 | 0.030 |
Why?
|
| Mixed Function Oxygenases | 1 | 1995 | 265 | 0.030 |
Why?
|
| Rare Diseases | 1 | 2019 | 622 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 2018 | 869 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2015 | 550 | 0.030 |
Why?
|
| Developed Countries | 1 | 1997 | 450 | 0.030 |
Why?
|
| Obstetric Labor Complications | 1 | 2016 | 236 | 0.030 |
Why?
|
| Infertility | 1 | 2000 | 654 | 0.030 |
Why?
|
| Cross-Cultural Comparison | 1 | 2017 | 634 | 0.030 |
Why?
|
| Poultry | 1 | 2013 | 80 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 36401 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2002 | 2025 | 0.030 |
Why?
|
| Gadolinium DTPA | 1 | 2017 | 823 | 0.030 |
Why?
|
| Cluster Analysis | 2 | 2014 | 2703 | 0.030 |
Why?
|
| Organomercury Compounds | 1 | 1993 | 16 | 0.030 |
Why?
|
| Vulnerable Populations | 1 | 2019 | 705 | 0.030 |
Why?
|
| Zinc | 1 | 2017 | 687 | 0.030 |
Why?
|
| Serologic Tests | 1 | 2015 | 381 | 0.030 |
Why?
|
| Dentition | 1 | 2013 | 20 | 0.030 |
Why?
|
| T-Box Domain Proteins | 1 | 2016 | 469 | 0.030 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 6403 | 0.030 |
Why?
|
| Los Angeles | 1 | 2013 | 244 | 0.030 |
Why?
|
| Program Evaluation | 2 | 2015 | 2486 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2018 | 2063 | 0.030 |
Why?
|
| Plant Leaves | 1 | 2013 | 150 | 0.030 |
Why?
|
| North Carolina | 1 | 2013 | 322 | 0.030 |
Why?
|
| Sunbathing | 1 | 2013 | 65 | 0.030 |
Why?
|
| Sulfhydryl Compounds | 1 | 2014 | 301 | 0.030 |
Why?
|
| Reproductive Physiological Phenomena | 1 | 2012 | 4 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2004 | 4739 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2015 | 491 | 0.030 |
Why?
|
| Factor VIII | 1 | 2015 | 348 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 2 | 2005 | 596 | 0.030 |
Why?
|
| Disease Progression | 1 | 2009 | 13495 | 0.030 |
Why?
|
| Research Subjects | 1 | 2014 | 249 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2010 | 6126 | 0.030 |
Why?
|
| Hemoglobins | 1 | 1998 | 1524 | 0.030 |
Why?
|
| Politics | 1 | 1999 | 813 | 0.030 |
Why?
|
| Endosonography | 1 | 2016 | 608 | 0.030 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2016 | 311 | 0.020 |
Why?
|
| Anticholesteremic Agents | 1 | 2019 | 967 | 0.020 |
Why?
|
| Insulin | 2 | 2014 | 6593 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2020 | 2764 | 0.020 |
Why?
|
| Biodiversity | 1 | 2015 | 345 | 0.020 |
Why?
|
| Disease-Free Survival | 2 | 2013 | 6807 | 0.020 |
Why?
|
| Colombia | 1 | 2012 | 282 | 0.020 |
Why?
|
| Urothelium | 1 | 2014 | 269 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2020 | 1956 | 0.020 |
Why?
|
| Imidazoles | 1 | 1998 | 1175 | 0.020 |
Why?
|
| Magnesium | 1 | 2015 | 804 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2013 | 880 | 0.020 |
Why?
|
| Aminopeptidases | 1 | 2012 | 95 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2013 | 524 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2009 | 11512 | 0.020 |
Why?
|
| Plants, Medicinal | 2 | 2003 | 165 | 0.020 |
Why?
|
| Metagenome | 1 | 2015 | 448 | 0.020 |
Why?
|
| DNA Probes, HPV | 1 | 2011 | 21 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2014 | 682 | 0.020 |
Why?
|
| Hepatitis B Vaccines | 1 | 2012 | 177 | 0.020 |
Why?
|
| Fires | 1 | 2012 | 171 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 2 | 2007 | 1624 | 0.020 |
Why?
|
| Bangladesh | 1 | 2013 | 732 | 0.020 |
Why?
|
| Models, Immunological | 1 | 2013 | 512 | 0.020 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2012 | 224 | 0.020 |
Why?
|
| Safety Management | 1 | 1997 | 760 | 0.020 |
Why?
|
| Hypopharynx | 1 | 2011 | 53 | 0.020 |
Why?
|
| Internet | 3 | 2012 | 3094 | 0.020 |
Why?
|
| Human papillomavirus 18 | 1 | 2012 | 125 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 3776 | 0.020 |
Why?
|
| von Willebrand Factor | 1 | 2015 | 676 | 0.020 |
Why?
|
| Carbon-Sulfur Lyases | 1 | 2010 | 17 | 0.020 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2012 | 293 | 0.020 |
Why?
|
| Oils | 1 | 1991 | 56 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2013 | 2185 | 0.020 |
Why?
|
| Hair Color | 1 | 2011 | 131 | 0.020 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2012 | 361 | 0.020 |
Why?
|
| Patient Selection | 2 | 2015 | 4237 | 0.020 |
Why?
|
| Group III Phospholipases A2 | 1 | 2009 | 1 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2012 | 489 | 0.020 |
Why?
|
| Skin Care | 1 | 2010 | 56 | 0.020 |
Why?
|
| Volatilization | 2 | 2002 | 77 | 0.020 |
Why?
|
| Fertility | 1 | 1995 | 769 | 0.020 |
Why?
|
| Bacterial Proteins | 2 | 2015 | 3842 | 0.020 |
Why?
|
| Protective Devices | 1 | 2010 | 72 | 0.020 |
Why?
|
| Stillbirth | 1 | 2013 | 368 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 1551 | 0.020 |
Why?
|
| Group VI Phospholipases A2 | 1 | 2009 | 16 | 0.020 |
Why?
|
| Hydroxyprostaglandin Dehydrogenases | 1 | 2009 | 31 | 0.020 |
Why?
|
| Turkmenistan | 1 | 2009 | 3 | 0.020 |
Why?
|
| Cotton Fiber | 1 | 2009 | 25 | 0.020 |
Why?
|
| Receptors, Prostaglandin E, EP2 Subtype | 1 | 2009 | 48 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2020 | 2909 | 0.020 |
Why?
|
| Receptors, Prostaglandin E | 1 | 2009 | 56 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2019 | 2378 | 0.020 |
Why?
|
| Veterans | 2 | 2014 | 2649 | 0.020 |
Why?
|
| Genetics, Population | 2 | 2005 | 935 | 0.020 |
Why?
|
| Dimethylhydrazines | 1 | 1989 | 12 | 0.020 |
Why?
|
| Hematologic Diseases | 1 | 1994 | 496 | 0.020 |
Why?
|
| Siberia | 1 | 2009 | 30 | 0.020 |
Why?
|
| Hospitals, Public | 1 | 2011 | 201 | 0.020 |
Why?
|
| Azacitidine | 1 | 2011 | 335 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2019 | 2018 | 0.020 |
Why?
|
| Household Products | 1 | 2009 | 27 | 0.020 |
Why?
|
| Osteosarcoma | 1 | 2015 | 896 | 0.020 |
Why?
|
| Biopsy | 2 | 2013 | 6763 | 0.020 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2009 | 69 | 0.020 |
Why?
|
| Immunohistochemistry | 3 | 2009 | 11069 | 0.020 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2009 | 99 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2014 | 802 | 0.020 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2011 | 258 | 0.020 |
Why?
|
| Cell Line, Tumor | 3 | 2011 | 16968 | 0.020 |
Why?
|
| Succinates | 1 | 1989 | 81 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2018 | 4269 | 0.020 |
Why?
|
| Respiratory Insufficiency | 1 | 1998 | 1230 | 0.020 |
Why?
|
| gamma-Tocopherol | 1 | 2008 | 30 | 0.020 |
Why?
|
| Self Concept | 1 | 2015 | 1046 | 0.020 |
Why?
|
| Neck | 1 | 2013 | 734 | 0.020 |
Why?
|
| Geriatric Assessment | 1 | 2016 | 1411 | 0.020 |
Why?
|
| Heme | 1 | 2011 | 313 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2018 | 10429 | 0.020 |
Why?
|
| Creatinine | 1 | 2014 | 1895 | 0.020 |
Why?
|
| Propensity Score | 1 | 2016 | 1912 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 8516 | 0.020 |
Why?
|
| Infectious Mononucleosis | 1 | 2009 | 133 | 0.020 |
Why?
|
| Gastrectomy | 1 | 2013 | 671 | 0.020 |
Why?
|
| Abortion, Spontaneous | 1 | 2013 | 532 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2014 | 1663 | 0.020 |
Why?
|
| Keratin-19 | 1 | 2008 | 33 | 0.020 |
Why?
|
| Thymidylate Synthase | 1 | 2008 | 74 | 0.020 |
Why?
|
| Heterocyclic Compounds | 1 | 2009 | 245 | 0.020 |
Why?
|
| Seasons | 1 | 2014 | 1518 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2010 | 416 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2009 | 767 | 0.020 |
Why?
|
| TRPV Cation Channels | 1 | 2009 | 243 | 0.020 |
Why?
|
| Panic Disorder | 1 | 2011 | 613 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2009 | 517 | 0.020 |
Why?
|
| Vitamin B Complex | 1 | 2010 | 299 | 0.020 |
Why?
|
| Antigens, CD | 2 | 2009 | 3998 | 0.020 |
Why?
|
| Siblings | 1 | 2012 | 824 | 0.020 |
Why?
|
| Patient Care Team | 1 | 1999 | 2515 | 0.020 |
Why?
|
| Esophagus | 1 | 2014 | 1031 | 0.020 |
Why?
|
| Quartz | 1 | 2007 | 23 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2019 | 2175 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2011 | 1635 | 0.020 |
Why?
|
| 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2007 | 28 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2019 | 2746 | 0.020 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2009 | 220 | 0.020 |
Why?
|
| Leukemia, Myeloid | 1 | 1990 | 693 | 0.020 |
Why?
|
| Sociology | 1 | 2006 | 21 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2007 | 237 | 0.020 |
Why?
|
| Genes, erbB-2 | 1 | 2007 | 162 | 0.020 |
Why?
|
| Hospitals | 2 | 2012 | 3879 | 0.020 |
Why?
|
| Multigene Family | 1 | 2010 | 1076 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2014 | 1962 | 0.020 |
Why?
|
| Control Groups | 1 | 2006 | 104 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2013 | 1502 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2009 | 391 | 0.020 |
Why?
|
| Cyclin D | 1 | 2006 | 72 | 0.020 |
Why?
|
| Calcium, Dietary | 1 | 2009 | 529 | 0.020 |
Why?
|
| Risk Adjustment | 1 | 2010 | 600 | 0.020 |
Why?
|
| Pyridines | 1 | 1998 | 2875 | 0.020 |
Why?
|
| Emigration and Immigration | 2 | 2000 | 397 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2008 | 469 | 0.020 |
Why?
|
| Religion | 1 | 2009 | 376 | 0.020 |
Why?
|
| Tissue Fixation | 1 | 2007 | 241 | 0.020 |
Why?
|
| Codon, Nonsense | 1 | 2007 | 284 | 0.020 |
Why?
|
| Graphite | 1 | 2006 | 78 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2012 | 1027 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2009 | 659 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 1996 | 1662 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 1454 | 0.020 |
Why?
|
| MEDLINE | 1 | 2006 | 119 | 0.020 |
Why?
|
| Butter | 1 | 2005 | 22 | 0.020 |
Why?
|
| Bread | 1 | 2005 | 23 | 0.020 |
Why?
|
| Protein Binding | 1 | 1998 | 9345 | 0.020 |
Why?
|
| Book Industry | 1 | 2005 | 1 | 0.020 |
Why?
|
| Carcinoma, Lobular | 1 | 2010 | 480 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 1608 | 0.020 |
Why?
|
| Glucuronates | 1 | 2005 | 40 | 0.020 |
Why?
|
| Prostatectomy | 1 | 2013 | 1825 | 0.020 |
Why?
|
| Neutralization Tests | 1 | 2007 | 725 | 0.020 |
Why?
|
| Allergens | 1 | 2013 | 1429 | 0.020 |
Why?
|
| Schools | 1 | 2014 | 1483 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2016 | 3017 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2010 | 754 | 0.020 |
Why?
|
| Rectum | 1 | 2010 | 891 | 0.020 |
Why?
|
| Pyrenes | 1 | 2005 | 49 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2015 | 2688 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2016 | 2632 | 0.020 |
Why?
|
| Military Personnel | 1 | 2014 | 1245 | 0.020 |
Why?
|
| Acetylation | 1 | 2008 | 1055 | 0.020 |
Why?
|
| Threshold Limit Values | 1 | 2004 | 12 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 2789 | 0.020 |
Why?
|
| Arylsulfotransferase | 1 | 2004 | 26 | 0.010 |
Why?
|
| HIV Antibodies | 1 | 2011 | 1302 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2011 | 2189 | 0.010 |
Why?
|
| Codeine | 1 | 2004 | 51 | 0.010 |
Why?
|
| Cyclins | 1 | 2006 | 594 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2003 | 12116 | 0.010 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2004 | 95 | 0.010 |
Why?
|
| Hygiene | 1 | 2004 | 94 | 0.010 |
Why?
|
| Meningioma | 1 | 2012 | 1215 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2010 | 2194 | 0.010 |
Why?
|
| Contrast Media | 1 | 2017 | 5305 | 0.010 |
Why?
|
| Xeroderma Pigmentosum Group D Protein | 1 | 2003 | 106 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 2527 | 0.010 |
Why?
|
| Malnutrition | 1 | 2009 | 622 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2007 | 1490 | 0.010 |
Why?
|
| Depressive Disorder | 1 | 2015 | 3735 | 0.010 |
Why?
|
| Korea | 1 | 2002 | 98 | 0.010 |
Why?
|
| Mutagenicity Tests | 1 | 2002 | 46 | 0.010 |
Why?
|
| Homozygote | 1 | 2007 | 1776 | 0.010 |
Why?
|
| Physical Examination | 1 | 2008 | 1254 | 0.010 |
Why?
|
| Sampling Studies | 2 | 1998 | 615 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2006 | 793 | 0.010 |
Why?
|
| Dental Amalgam | 1 | 2002 | 66 | 0.010 |
Why?
|
| Sinusitis | 1 | 2011 | 991 | 0.010 |
Why?
|
| Point Mutation | 1 | 2007 | 1595 | 0.010 |
Why?
|
| Walking | 1 | 2009 | 1197 | 0.010 |
Why?
|
| Colon | 1 | 2010 | 1791 | 0.010 |
Why?
|
| USSR | 1 | 2001 | 18 | 0.010 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2007 | 557 | 0.010 |
Why?
|
| Time | 1 | 2003 | 545 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2015 | 6233 | 0.010 |
Why?
|
| Substance Abuse Detection | 1 | 2004 | 301 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2013 | 4470 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 7403 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2006 | 1333 | 0.010 |
Why?
|
| Inpatients | 1 | 2012 | 2545 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2001 | 813 | 0.010 |
Why?
|
| Morphine | 1 | 2004 | 655 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2013 | 3077 | 0.010 |
Why?
|
| Armenia | 1 | 1999 | 15 | 0.010 |
Why?
|
| Mental Recall | 1 | 2006 | 1222 | 0.010 |
Why?
|
| Sex | 1 | 1999 | 53 | 0.010 |
Why?
|
| Suicide | 2 | 2004 | 1601 | 0.010 |
Why?
|
| HIV Seronegativity | 1 | 2000 | 211 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2000 | 11735 | 0.010 |
Why?
|
| Cell Movement | 1 | 2011 | 5201 | 0.010 |
Why?
|
| Nervous System | 1 | 2002 | 545 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2005 | 1742 | 0.010 |
Why?
|
| Medicare | 1 | 2016 | 6774 | 0.010 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 1998 | 354 | 0.010 |
Why?
|
| Africa | 1 | 2000 | 714 | 0.010 |
Why?
|
| Glioma | 1 | 2012 | 3452 | 0.010 |
Why?
|
| Dietary Sucrose | 1 | 1999 | 243 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1998 | 661 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2002 | 1964 | 0.010 |
Why?
|
| Cell Line | 1 | 2011 | 15577 | 0.010 |
Why?
|
| DDT | 1 | 1996 | 32 | 0.010 |
Why?
|
| Mental Health | 1 | 2011 | 3253 | 0.010 |
Why?
|
| Liver | 1 | 2012 | 7512 | 0.010 |
Why?
|
| Skin | 1 | 2010 | 4472 | 0.010 |
Why?
|
| Mental Disorders | 1 | 1996 | 6826 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2001 | 2340 | 0.010 |
Why?
|
| Glutathione | 1 | 1999 | 582 | 0.010 |
Why?
|
| Transients and Migrants | 1 | 1999 | 165 | 0.010 |
Why?
|
| Paris | 1 | 1995 | 41 | 0.010 |
Why?
|
| Gene Expression | 1 | 2009 | 7569 | 0.010 |
Why?
|
| Nitrogen Oxides | 1 | 1996 | 129 | 0.010 |
Why?
|
| Quality of Life | 1 | 2017 | 13359 | 0.010 |
Why?
|
| Schistosomiasis haematobia | 1 | 1994 | 15 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2005 | 2916 | 0.010 |
Why?
|
| Cardiovascular System | 1 | 2002 | 834 | 0.010 |
Why?
|
| Zimbabwe | 1 | 1994 | 135 | 0.010 |
Why?
|
| Telephone | 1 | 1998 | 626 | 0.010 |
Why?
|
| Stem Cells | 1 | 2007 | 3514 | 0.010 |
Why?
|
| Workers' Compensation | 1 | 1994 | 150 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2005 | 2878 | 0.010 |
Why?
|
| Diabetic Angiopathies | 1 | 1999 | 803 | 0.010 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2011 | 4575 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2009 | 3752 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2010 | 8998 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2002 | 1896 | 0.010 |
Why?
|
| Depression | 1 | 2011 | 8132 | 0.010 |
Why?
|
| Unemployment | 1 | 1993 | 210 | 0.010 |
Why?
|
| Schizophrenia | 1 | 2009 | 6929 | 0.010 |
Why?
|
| Algorithms | 1 | 2010 | 14024 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1999 | 2090 | 0.000 |
Why?
|
| Kidney | 1 | 2002 | 7044 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1998 | 12759 | 0.000 |
Why?
|
| Parents | 1 | 1994 | 3563 | 0.000 |
Why?
|